BCL-6	B-protein
,	O
a	O
POZ/zinc-finger	B-protein
protein	I-protein
,	O
is	O
a	O
sequence-specific	B-protein
transcriptional	I-protein
repressor	I-protein
.	O

Approximately	O
40	O
%	O
of	O
diffuse	O
large	O
cell	O
lymphoma	O
are	O
associated	O
with	O
chromosomal	O
translocations	O
that	O
deregulate	O
the	O
expression	O
of	O
the	O
BCL6	B-DNA
gene	I-DNA
by	O
juxtaposing	O
heterologous	B-DNA
promoters	I-DNA
to	O
the	O
BCL-6	B-DNA
coding	I-DNA
domain	I-DNA
.	O

The	O
BCL6	B-DNA
gene	I-DNA
encodes	O
a	O
95-kDa	B-protein
protein	I-protein
containing	O
six	O
C-terminal	B-protein
zinc-finger	I-protein
motifs	I-protein
and	O
an	O
N-terminal	B-protein
POZ	I-protein
domain	I-protein
,	O
suggesting	O
that	O
it	O
may	O
function	O
as	O
a	O
transcription	B-protein
factor	I-protein
.	O

By	O
using	O
a	O
DNA	B-DNA
sequence	I-DNA
selected	O
for	O
its	O
ability	O
to	O
bind	O
recombinant	B-protein
BCL-6	I-protein
in	O
vitro	O
,	O
we	O
show	O
here	O
that	O
BCL-6	B-protein
is	O
present	O
in	O
DNA-binding	B-protein
complexes	I-protein
in	O
nuclear	O
extracts	O
from	O
various	O
B-cell	B-cell_line
lines	I-cell_line
.	O

In	O
transient	O
transfectin	O
experiments	O
,	O
BCL6	B-protein
can	O
repress	O
transcription	O
from	O
promoters	B-DNA
linked	O
to	O
its	O
DNA	B-DNA
target	I-DNA
sequence	I-DNA
and	O
this	O
activity	O
is	O
dependent	O
upon	O
specific	O
DNA-binding	O
and	O
the	O
presence	O
of	O
an	O
intact	O
N-terminal	B-protein
half	I-protein
of	O
the	O
protein	O
.	O

We	O
demonstrate	O
that	O
this	O
part	O
of	O
the	O
BCL6	B-protein
molecule	I-protein
contains	O
an	O
autonomous	B-protein
transrepressor	I-protein
domain	I-protein
and	O
that	O
two	O
noncontiguous	B-protein
regions	I-protein
,	O
including	O
the	O
POZ	B-protein
motif	I-protein
,	O
mediate	O
maximum	O
transrepressive	O
activity	O
.	O

These	O
results	O
indicate	O
that	O
the	O
BCL-6	B-protein
protein	I-protein
can	O
function	O
as	O
a	O
sequence-specific	B-protein
transcriptional	I-protein
repressor	I-protein
and	O
have	O
implications	O
for	O
the	O
role	O
of	O
BCL6	B-protein
in	O
normal	O
lymphoid	O
development	O
and	O
lymphomagenesis	O
.	O

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
Vol	NULL
.	NULL

93	NULL
,	NULL
pp	NULL
.	NULL

6947-6952	NULL
,	NULL
July	NULL
1996	NULL
Biochemistry	NULL
BCL-6	NULL
,	NULL
a	NULL
POZ/zinc-finger	NULL
protein	NULL
,	NULL
is	NULL
a	NULL
sequence-specific	NULL
transcriptional	NULL
repressor	NULL
CHim-CHao	NULL
CHaNng*	NULL
,	NULL
Bimut	NULL
H.	NULL
YE*	NULL
,	NULL
R.	NULL
S.	NULL
K.	NULL
CHagANTIT	NULL
,	NULL
AND	NULL
RICCARDO	NULL
DALLA-FAvERA**	NULL
*Division	NULL
of	NULL
Oncology	NULL
,	NULL
Department	NULL
of	NULL
Pathology	NULL
,	NULL
and	NULL
Department	NULL
of	NULL
Genetics	NULL
and	NULL
Development	NULL
,	NULL
College	NULL
of	NULL
Physicians	NULL
and	NULL
Surgeons	NULL
,	NULL
Columbia	NULL
University	NULL
,	NULL
New	NULL
York	NULL
,	NULL
NY	NULL
10032	NULL
;	NULL
and	NULL
*Cell	NULL
Biology	NULL
and	NULL
Genetics	NULL
Program	NULL
,	NULL
Memorial	NULL
Sloan-Kettering	NULL
Cancer	NULL
Center	NULL
,	NULL
New	NULL
York	NULL
,	NULL
NY	NULL
10021	NULL
Communicated	NULL
by	NULL
Robert	NULL
C.	NULL
Gallo	NULL
,	NULL
University	NULL
of	NULL
Maryland	NULL
,	NULL
Baltimore	NULL
,	NULL
MD	NULL
,	NULL
March	NULL
22	NULL
,	NULL
1996	NULL
(	NULL
received	NULL
for	NULL
review	NULL
December	NULL
29	NULL
,	NULL
1995	NULL
)	NULL
ABSTRACT	NULL
Approximately	NULL
40	NULL
%	NULL
of	NULL
diffuse	NULL
large	NULL
cell	NULL
lymphoma	NULL
are	NULL
associated	NULL
with	NULL
chromosomal	NULL
translocations	NULL
that	NULL
deregulate	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
BCLG	NULL
gene	NULL
by	NULL
juxtaposing	NULL
heterologous	NULL
promoters	NULL
to	NULL
the	NULL
BCL-6	NULL
coding	NULL
domain	NULL
.	NULL

The	NULL
BCL6	NULL
gene	NULL
encodes	NULL
a	NULL
95-kDa	NULL
protein	NULL
containing	NULL
six	NULL
C-terminal	NULL
zinc-finger	NULL
motifs	NULL
and	NULL
an	NULL
N-terminal	NULL
POZ	NULL
domain	NULL
,	NULL
suggesting	NULL
that	NULL
it	NULL
may	NULL
function	NULL
as	NULL
a	NULL
transcription	NULL
factor	NULL
.	NULL

By	NULL
using	NULL
a	NULL
DNA	NULL
sequence	NULL
selected	NULL
for	NULL
its	NULL
ability	NULL
to	NULL
bind	NULL
recombinant	NULL
BCL-6	NULL
in	NULL
vitro	NULL
,	NULL
we	NULL
show	NULL
here	NULL
that	NULL
BCL-6	NULL
is	NULL
present	NULL
in	NULL
DNA-binding	NULL
complexes	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
various	NULL
B-cell	NULL
lines	NULL
.	NULL

In	NULL
transient	NULL
transfection	NULL
experiments	NULL
,	NULL
BCL6	NULL
can	NULL
repress	NULL
transcription	NULL
from	NULL
promoters	NULL
linked	NULL
to	NULL
its	NULL
DNA	NULL
target	NULL
sequence	NULL
and	NULL
this	NULL
activity	NULL
is	NULL
dependent	NULL
upon	NULL
specific	NULL
DNA-binding	NULL
and	NULL
the	NULL
presence	NULL
of	NULL
an	NULL
intact	NULL
N-terminal	NULL
half	NULL
of	NULL
the	NULL
protein	NULL
.	NULL

We	NULL
demonstrate	NULL
that	NULL
this	NULL
part	NULL
of	NULL
the	NULL
BCL6	NULL
molecule	NULL
contains	NULL
an	NULL
autonomous	NULL
transrepressor	NULL
domain	NULL
and	NULL
that	NULL
two	NULL
noncontiguous	NULL
regions	NULL
,	NULL
including	NULL
the	NULL
POZ	NULL
motif	NULL
,	NULL
mediate	NULL
maximum	NULL
transrepressive	NULL
activity	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
BCL-6	NULL
protein	NULL
can	NULL
function	NULL
as	NULL
a	NULL
sequence-specific	NULL
transcriptional	NULL
repressor	NULL
and	NULL
have	NULL
implications	NULL
for	NULL
the	NULL
role	NULL
of	NULL
BCL6	NULL
in	NULL
normal	NULL
lymphoid	NULL
development	NULL
and	NULL
lymphomagenesis	NULL
.	NULL

The	NULL
BCL6	NULL
gene	NULL
was	NULL
identified	NULL
by	NULL
virtue	NULL
of	NULL
its	NULL
involvement	NULL
in	NULL
chromosomal	NULL
translocations	NULL
affecting	NULL
band	NULL
3q27	NULL
in	NULL
non-Hodgkin	NULL
lymphoma	NULL
(	NULL
1-5	NULL
)	NULL
.	NULL

Subsequent	NULL
studies	NULL
have	NULL
demonstrated	NULL
that	NULL
rearrangements	NULL
of	NULL
the	NULL
BCL	NULL
6	NULL
gene	NULL
can	NULL
be	NULL
found	NULL
in	NULL
30-40	NULL
%	NULL
of	NULL
diffuse	NULL
large	NULL
cell	NULL
lymphoma	NULL
and	NULL
6-11	NULL
%	NULL
follicular	NULL
lymphoma	NULL
(	NULL
6-8	NULL
)	NULL
.	NULL

These	NULL
alterations	NULL
cause	NULL
the	NULL
deregulated	NULL
expression	NULL
of	NULL
the	NULL
BCL	NULL
6	NULL
gene	NULL
by	NULL
a	NULL
mechanism	NULL
called	NULL
promoter	NULL
substitution	NULL
,	NULL
that	NULL
is	NULL
the	NULL
juxtaposition	NULL
of	NULL
heterologous	NULL
promoters	NULL
,	NULL
derived	NULL
from	NULL
other	NULL
chromosomes	NULL
,	NULL
to	NULL
the	NULL
BCL-6	NULL
coding	NULL
domain	NULL
(	NULL
9	NULL
)	NULL
.	NULL

Recent	NULL
evidence	NULL
also	NULL
indicates	NULL
that	NULL
the	NULL
5	NULL
'	NULL
non-coding	NULL
region	NULL
of	NULL
the	NULL
BCL6	NULL
gene	NULL
is	NULL
altered	NULL
by	NULL
somatic	NULL
point	NULL
mutations	NULL
that	NULL
are	NULL
found	NULL
,	NULL
independent	NULL
of	NULL
rearrangements	NULL
,	NULL
in	NULL
~70	NULL
%	NULL
diffuse	NULL
large	NULL
cell	NULL
lymphoma	NULL
and	NULL
45	NULL
%	NULL
follicular	NULL
lymphoma	NULL
(	NULL
10	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
most	NULL
cases	NULL
of	NULL
diffuse	NULL
large	NULL
cell	NULL
lymphoma	NULL
and	NULL
a	NULL
significant	NULL
fraction	NULL
of	NULL
follicular	NULL
lymphoma	NULL
carry	NULL
structural	NULL
alterations	NULL
of	NULL
the	NULL
regulatory	NULL
region	NULL
of	NULL
the	NULL
BCL6	NULL
gene	NULL
,	NULL
suggesting	NULL
that	NULL
deregulated	NULL
BCLG6	NULL
expression	NULL
may	NULL
be	NULL
important	NULL
for	NULL
lymphomagenesis	NULL
(	NULL
11	NULL
)	NULL
.	NULL

The	NULL
BCL-6	NULL
protein	NULL
is	NULL
a	NULL
95-kDa	NULL
nuclear	NULL
phosphoprotein	NULL
detectable	NULL
at	NULL
low	NULL
abundance	NULL
in	NULL
multiple	NULL
tissues	NULL
and	NULL
expressed	NULL
at	NULL
high	NULL
levels	NULL
exclusively	NULL
in	NULL
mature	NULL
B	NULL
cells	NULL
(	NULL
12-14	NULL
)	NULL
.	NULL

Within	NULL
the	NULL
B-cell	NULL
lineage	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
BCL-6	NULL
protein	NULL
is	NULL
specifically	NULL
regulated	NULL
during	NULL
differentiation	NULL
since	NULL
it	NULL
is	NULL
only	NULL
detectable	NULL
in	NULL
B	NULL
cells	NULL
within	NULL
germinal	NULL
centers	NULL
(	NULL
GCs	NULL
)	NULL
but	NULL
not	NULL
in	NULL
pre-GC	NULL
cells	NULL
or	NULL
in	NULL
differentiated	NULL
progenies	NULL
such	NULL
as	NULL
plasma	NULL
cells	NULL
(	NULL
12-14	NULL
)	NULL
.	NULL

The	NULL
structure	NULL
of	NULL
the	NULL
BCL-6	NULL
protein	NULL
includes	NULL
six	NULL
Kriippel-type	NULL
C-terminal	NULL
zinc-finger	NULL
(	NULL
ZF	NULL
)	NULL
motifs	NULL
(	NULL
2	NULL
,	NULL
4	NULL
,	NULL
5	NULL
)	NULL
which	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
recognize	NULL
specific	NULL
DNA	NULL
sequences	NULL
in	NULL
vitro	NULL
(	NULL
15	NULL
,	NULL
16	NULL
)	NULL
,	NULL
and	NULL
a	NULL
N-terminal	NULL
POZ	NULL
(	NULL
also	NULL
called	NULL
ZIN	NULL
or	NULL
BTB	NULL
;	NULL
refs	NULL
.	NULL

17-19	NULL
)	NULL
motif	NULL
shared	NULL
by	NULL
various	NULL
ZF	NULL
molecules	NULL
including	NULL
the	NULL
Drosophila	NULL
develop	NULL
The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

§1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

6947	NULL
mental	NULL
regulators	NULL
Tramtrack	NULL
and	NULL
Broad-complex	NULL
(	NULL
20	NULL
,	NULL
21	NULL
)	NULL
,	NULL
the	NULL
human	NULL
KUP	NULL
(	NULL
22	NULL
)	NULL
,	NULL
ZID	NULL
(	NULL
19	NULL
)	NULL
,	NULL
and	NULL
PLZF	NULL
(	NULL
23	NULL
)	NULL
proteins	NULL
as	NULL
well	NULL
as	NULL
by	NULL
POX	NULL
viruses	NULL
(	NULL
24	NULL
)	NULL
and	NULL
the	NULL
actin-binding	NULL
Drosophila	NULL
oocyte	NULL
protein	NULL
Keich	NULL
(	NULL
25	NULL
)	NULL
.	NULL

These	NULL
structural	NULL
features	NULL
and	NULL
the	NULL
expression	NULL
pattern	NULL
of	NULL
the	NULL
BCL-6	NULL
protein	NULL
suggest	NULL
that	NULL
it	NULL
may	NULL
function	NULL
as	NULL
a	NULL
transcription	NULL
factor	NULL
involved	NULL
in	NULL
the	NULL
control	NULL
of	NULL
B-cell	NULL
development	NULL
.	NULL

This	NULL
study	NULL
was	NULL
aimed	NULL
at	NULL
elucidating	NULL
the	NULL
role	NULL
of	NULL
BCLG6	NULL
in	NULL
transcriptional	NULL
regulation	NULL
.	NULL

We	NULL
demonstrate	NULL
that	NULL
BCL6	NULL
functions	NULL
as	NULL
a	NULL
potent	NULL
transcriptional	NULL
repressor	NULL
of	NULL
promoters	NULL
linked	NULL
to	NULL
its	NULL
DNA	NULL
target	NULL
sequence	NULL
and	NULL
we	NULL
map	NULL
this	NULL
transrepression	NULL
activity	NULL
to	NULL
two	NULL
noncontiguous	NULL
N-terminal	NULL
regions	NULL
of	NULL
the	NULL
protein	NULL
,	NULL
one	NULL
of	NULL
them	NULL
including	NULL
the	NULL
POZ	NULL
domain	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Plasmids	NULL
.	NULL

The	NULL
eukaryotic	NULL
expression	NULL
vector	NULL
pMT2-BCL-6	NULL
has	NULL
been	NULL
described	NULL
(	NULL
12	NULL
)	NULL
.	NULL

To	NULL
construct	NULL
the	NULL
plasmids	NULL
expressing	NULL
the	NULL
Gal4-BCL-6	NULL
fusion	NULL
proteins	NULL
,	NULL
various	NULL
segments	NULL
of	NULL
BCL6	NULL
cDNA	NULL
were	NULL
first	NULL
obtained	NULL
by	NULL
polymerase	NULL
chain	NULL
reaction	NULL
(	NULL
PCR	NULL
)	NULL
using	NULL
pairs	NULL
of	NULL
oligonucleotide	NULL
primers	NULL
in	NULL
which	NULL
BCL6-specific	NULL
sequences	NULL
are	NULL
linked	NULL
to	NULL
a	NULL
BamHI	NULL
restriction	NULL
site	NULL
and	NULL
then	NULL
subcloned	NULL
into	NULL
the	NULL
BamHI	NULL
restriction	NULL
site	NULL
of	NULL
the	NULL
Gal4	NULL
plasmid	NULL
(	NULL
26	NULL
)	NULL
.	NULL

To	NULL
construct	NULL
Gal4-BCL-6	NULL
fusion	NULL
protein	NULL
plasmids	NULL
with	NULL
internal	NULL
BCL6	NULL
deletions	NULL
(	NULL
constructs	NULL
J	NULL
,	NULL
K	NULL
,	NULL
and	NULL
L	NULL
;	NULL
see	NULL
Fig	NULL
.	NULL

54	NULL
)	NULL
,	NULL
BCL6	NULL
cDNAs	NULL
were	NULL
first	NULL
obtained	NULL
by	NULL
PCR	NULL
using	NULL
BCL	NULL
6	NULL
primers	NULL
linked	NULL
to	NULL
a	NULL
5	NULL
EcoRI	NULL
site	NULL
and	NULL
a	NULL
3	NULL
'	NULL
Smal	NULL
site	NULL
and	NULL
then	NULL
cloned	NULL
into	NULL
the	NULL
Gal4	NULL
plasmid	NULL
to	NULL
form	NULL
an	NULL
intermediate	NULL
fusion	NULL
protein	NULL
construct	NULL
.	NULL

A	NULL
second	NULL
BCL6	NULL
cDNA	NULL
obtained	NULL
using	NULL
primers	NULL
linked	NULL
to	NULL
a	NULL
5	NULL
'	NULL
Smal	NULL
site	NULL
and	NULL
3	NULL
'	NULL
BamHI	NULL
site	NULL
was	NULL
then	NULL
cloned	NULL
into	NULL
the	NULL
Smal/BamHI	NULL
sites	NULL
of	NULL
the	NULL
intermediate	NULL
fusion	NULL
protein	NULL
construct	NULL
to	NULL
create	NULL
the	NULL
final	NULL
construct	NULL
.	NULL

All	NULL
the	NULL
fusion	NULL
constructs	NULL
express	NULL
Gal4	NULL
(	NULL
amino	NULL
acids	NULL
1-147	NULL
)	NULL
fused	NULL
to	NULL
variable	NULL
domains	NULL
of	NULL
BCL6	NULL
via	NULL
five	NULL
residues	NULL
(	NULL
PEFPG	NULL
)	NULL
encoded	NULL
by	NULL
the	NULL
multiple	NULL
cloning	NULL
site	NULL
of	NULL
the	NULL
Gal4	NULL
plasmid	NULL
.	NULL

Translation	NULL
termination	NULL
is	NULL
provided	NULL
by	NULL
three-frame	NULL
termination	NULL
codons	NULL
in	NULL
the	NULL
Gal4	NULL
plasmid	NULL
.	NULL

All	NULL
PCR-derived	NULL
sequences	NULL
as	NULL
well	NULL
as	NULL
subcloning	NULL
junctions	NULL
were	NULL
verified	NULL
by	NULL
DNA	NULL
sequencing	NULL
.	NULL

B6BS-TK	NULL
LUC	NULL
was	NULL
constructed	NULL
by	NULL
insertion	NULL
of	NULL
a	NULL
single	NULL
copy	NULL
of	NULL
the	NULL
BCL	NULL
6	NULL
binding	NULL
site	NULL
(	NULL
B6BS	NULL
:	NULL
GAAAATTCCTA-GAAAGCATA	NULL
;	NULL
B.H.Y	NULL
.	NULL

et	NULL
al	NULL
.	NULL

,	NULL
unpublished	NULL
data	NULL
)	NULL
into	NULL
the	NULL
BamHI	NULL
site	NULL
of	NULL
TK-LUC	NULL
.	NULL

Luciferase	NULL
reporter	NULL
constructs	NULL
(	NULL
GS-TK-LUC	NULL
and	NULL
TK-LUC	NULL
)	NULL
were	NULL
obtained	NULL
from	NULL
K.	NULL
Calame	NULL
(	NULL
Columbia	NULL
Uni-versity	NULL
)	NULL
.	NULL

TK-CAT	NULL
reporter	NULL
constructs	NULL
[	NULL
G5	NULL
(	NULL
+1000	NULL
)	NULL
-TK-CAT	NULL
and	NULL
G5	NULL
(	NULL
-750	NULL
)	NULL
-TK-CATJand	NULL
SV-CAT	NULL
reporter	NULL
constructs	NULL
[	NULL
GS-SV-CAT	NULL
,	NULL
GS5-SV'-CAT	NULL
,	NULL
and	NULL
G5	NULL
(	NULL
110	NULL
)	NULL
-SV-CAT	NULL
]	NULL
were	NULL
obtained	NULL
from	NULL
L.	NULL
Lania	NULL
(	NULL
27	NULL
)	NULL
and	NULL
F.	NULL
Rauscher	NULL
(	NULL
28	NULL
)	NULL
,	NULL
respectively	NULL
(	NULL
TK	NULL
,	NULL
thymidine	NULL
kinase	NULL
;	NULL
CAT	NULL
,	NULL
chloramphenicol	NULL
acetyltransferase	NULL
;	NULL
LUC	NULL
,	NULL
lucif-erase	NULL
;	NULL
SV	NULL
,	NULL
simian	NULL
virus	NULL
)	NULL
.	NULL

Antisera	NULL
and	NULL
Immunoprecipitation	NULL
.	NULL

The	NULL
generation	NULL
and	NULL
characterization	NULL
of	NULL
polyclonal	NULL
anti-BCL-6	NULL
antisera	NULL
(	NULL
N7O-6	NULL
;	NULL
C€73-6	NULL
)	NULL
have	NULL
been	NULL
described	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Polyclonal	NULL
anti-yeast	NULL
Gal4	NULL
antiserum	NULL
was	NULL
obtained	NULL
from	NULL
Upstate	NULL
Biotechnology	NULL
(	NULL
Lake	NULL
Placid	NULL
,	NULL
NY	NULL
)	NULL
.	NULL

Cell	NULL
Lines	NULL
,	NULL
Transient	NULL
Transfection	NULL
,	NULL
and	NULL
Reporter	NULL
Gene	NULL
Assays	NULL
.	NULL

The	NULL
Mutu	NULL
I1	NULL
and	NULL
Mutu	NULL
III	NULL
cell	NULL
lines	NULL
were	NULL
obtained	NULL
from	NULL
A.	NULL
Abbreviations	NULL
:	NULL
ZF	NULL
,	NULL
zinc-finger	NULL
;	NULL
GC	NULL
,	NULL
germinal	NULL
center	NULL
;	NULL
CAT	NULL
,	NULL
chloramphenicol	NULL
acetyltransferase	NULL
;	NULL
SV	NULL
,	NULL
simain	NULL
virus	NULL
;	NULL
LUC	NULL
,	NULL
luciferase	NULL
,	NULL
EMSA	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
;	NULL
B6BS	NULL
,	NULL
BCL-6	NULL
binding	NULL
site	NULL
.	NULL

To	NULL
whom	NULL
reprint	NULL
requests	NULL
should	NULL
be	NULL
addressed	NULL
.	NULL

6948	NULL
-	NULL
Biochemistry	NULL
:	NULL
Chang	NULL
et	NULL
al	NULL
.	NULL

Rickinson	NULL
(	NULL
29	NULL
)	NULL
.	NULL

Transfections	NULL
of	NULL
Mutu	NULL
III	NULL
cells	NULL
(	NULL
1.5	NULL
x	NULL
10	NULL
``	NULL
)	NULL
were	NULL
performed	NULL
by	NULL
electroporation	NULL
using	NULL
Gene	NULL
Pulser	NULL
(	NULL
Bio-Rad	NULL
)	NULL
apparatus	NULL
.	NULL

Transfections	NULL
in	NULL
NTera-2	NULL
cells	NULL
(	NULL
from	NULL
U.	NULL
Siebenlist	NULL
,	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
)	NULL
,	NULL
293T	NULL
cells	NULL
(	NULL
from	NULL
J.	NULL
Krolewski	NULL
,	NULL
Columbia	NULL
University	NULL
)	NULL
,	NULL
and	NULL
NIH	NULL
3T3	NULL
cells	NULL
were	NULL
performed	NULL
by	NULL
calcium-phosphate	NULL
precipitation	NULL
procedure	NULL
(	NULL
30	NULL
)	NULL
.	NULL

Assays	NULL
for	NULL
LUC	NULL
and	NULL
CAT	NULL
activities	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
(	NULL
30	NULL
)	NULL
.	NULL

Electrophoretic	NULL
Mobility	NULL
Shift	NULL
Assay	NULL
(	NULL
EMSA	NULL
)	NULL
.	NULL

Preparation	NULL
of	NULL
nuclear	NULL
extracts	NULL
,	NULL
EMSA	NULL
,	NULL
and	NULL
antibody-mediated	NULL
supershift	NULL
assays	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
(	NULL
30	NULL
)	NULL
except	NULL
that	NULL
the	NULL
EMSA	NULL
reaction	NULL
buffer	NULL
was	NULL
20	NULL
mM	NULL
Hepes	NULL
(	NULL
pH	NULL
7.5	NULL
)	NULL
,	NULL
50	NULL
mM	NULL
KCI	NULL
,	NULL
5	NULL
mM	NULL
MgCl	NULL
;	NULL
,	NULL
10	NULL
uM	NULL
ZnCl	NULL
;	NULL
,	NULL
4	NULL
%	NULL
Glycerol	NULL
,	NULL
and	NULL
100	NULL
ug	NULL
of	NULL
BSA	NULL
per	NULL
ml	NULL
.	NULL

RESULTS	NULL
Specific	NULL
DNA-Binding	NULL
by	NULL
BCL-6	NULL
in	NULL
B-Cell	NULL
Nuclear	NULL
Extracts	NULL
.	NULL

Using	NULL
the	NULL
cyclic	NULL
amplification	NULL
and	NULL
selection	NULL
of	NULL
targets	NULL
(	NULL
CAST	NULL
)	NULL
method	NULL
(	NULL
31	NULL
)	NULL
,	NULL
we	NULL
have	NULL
identified	NULL
a	NULL
20-bp	NULL
DNA	NULL
B6BS	NULL
(	NULL
GAA-AATTCCTAGAAAGCATA	NULL
)	NULL
capable	NULL
of	NULL
binding	NULL
in	NULL
vitro	NULL
translated	NULL
or	NULL
bacterially	NULL
produced	NULL
BCLG6	NULL
(	NULL
B.H.Y	NULL
.	NULL

et	NULL
al	NULL
.	NULL

,	NULL
unpublished	NULL
data	NULL
)	NULL
.	NULL

Compared	NULL
with	NULL
the	NULL
sites	NULL
previously	NULL
reported	NULL
(	NULL
15	NULL
,	NULL
16	NULL
)	NULL
,	NULL
B6BS	NULL
contains	NULL
additional	NULL
flanking	NULL
residues	NULL
that	NULL
increase	NULL
affinity	NULL
and	NULL
contains	NULL
unequivocal	NULL
residues	NULL
at	NULL
various	NULL
previously	NULL
undefined	NULL
positions	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
B6BS	NULL
could	NULL
serve	NULL
as	NULL
a	NULL
target	NULL
for	NULL
naturally	NULL
synthesized	NULL
BCL-6	NULL
in	NULL
nuclear	NULL
extracts	NULL
,	NULL
we	NULL
used	NULL
it	NULL
as	NULL
a	NULL
probe	NULL
in	NULL
an	NULL
EMSA	NULL
by	NULL
using	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
B-cell	NULL
lines	NULL
expressing	NULL
(	NULL
Mutu	NULL
1	NULL
)	NULL
or	NULL
lacking	NULL
(	NULL
Mutu	NULL
III	NULL
)	NULL
BCL6	NULL
RNA	NULL
and	NULL
protein	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Fig	NULL
.	NULL

1	NULL
shows	NULL
that	NULL
a	NULL
DNA-binding	NULL
protein	NULL
complex	NULL
was	NULL
detectable	NULL
only	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
cells	NULL
expressing	NULL
BCL	NULL
6	NULL
(	NULL
Mutu	NULL
I	NULL
)	NULL
,	NULL
but	NULL
not	NULL
in	NULL
control	NULL
cells	NULL
(	NULL
Mutu	NULL
III	NULL
)	NULL
.	NULL

Cold	NULL
cognate	NULL
DNA	NULL
competition	NULL
showed	NULL
that	NULL
the	NULL
detected	NULL
complex	NULL
bound	NULL
B6BS	NULL
specifically	NULL
;	NULL
antibody-mediated	NULL
supershift	NULL
analysis	NULL
using	NULL
anti	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
93	NULL
(	NULL
1996	NULL
)	NULL
sera	NULL
against	NULL
the	NULL
N-terminus	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
or	NULL
the	NULL
C-terminus	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
of	NULL
BCL6	NULL
showed	NULL
that	NULL
this	NULL
complex	NULL
contained	NULL
BCL-6	NULL
and	NULL
that	NULL
the	NULL
full-length	NULL
protein	NULL
was	NULL
present	NULL
in	NULL
the	NULL
complex	NULL
.	NULL

Analogous	NULL
EMSA	NULL
performed	NULL
on	NULL
nuclear	NULL
extracts	NULL
from	NULL
a	NULL
panel	NULL
of	NULL
B	NULL
cells	NULL
representative	NULL
of	NULL
discrete	NULL
stages	NULL
of	NULL
B-cell	NULL
differentiation	NULL
indicated	NULL
complete	NULL
concordance	NULL
between	NULL
formation	NULL
of	NULL
BCL-6	NULL
containing	NULL
protein-DNA	NULL
complexes	NULL
and	NULL
protein	NULL
expression	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

As	NULL
a	NULL
further	NULL
control	NULL
for	NULL
specificity	NULL
,	NULL
we	NULL
compared	NULL
the	NULL
B6BS-binding	NULL
complexes	NULL
in	NULL
cells	NULL
(	NULL
NTera-2	NULL
;	NULL
lacking	NULL
BCL6	NULL
expression	NULL
)	NULL
transfected	NULL
with	NULL
a	NULL
BCL	NULL
6	NULL
expressing	NULL
vector	NULL
or	NULL
with	NULL
a	NULL
control	NULL
vector	NULL
(	NULL
30	NULL
)	NULL
.	NULL

The	NULL
result	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
shows	NULL
that	NULL
a	NULL
DNA-binding	NULL
complex	NULL
,	NULL
specific	NULL
for	NULL
B6BS	NULL
(	NULL
see	NULL
cold	NULL
cognate	NULL
competition	NULL
)	NULL
and	NULL
containing	NULL
BCL-6	NULL
(	NULL
see	NULL
supershift	NULL
analysis	NULL
)	NULL
,	NULL
is	NULL
also	NULL
detectable	NULL
in	NULL
BCL	NULL
6	NULL
transfected	NULL
cells	NULL
,	NULL
but	NULL
not	NULL
in	NULL
control-transfected	NULL
cells	NULL
.	NULL

The	NULL
complex	NULL
detected	NULL
in	NULL
NTera-2-transfected	NULL
cells	NULL
appeared	NULL
to	NULL
be	NULL
similar	NULL
in	NULL
migration	NULL
and	NULL
abundance	NULL
to	NULL
the	NULL
one	NULL
detected	NULL
in	NULL
B-cell	NULL
lines	NULL
,	NULL
suggesting	NULL
either	NULL
that	NULL
the	NULL
BCL-6	NULL
protein	NULL
is	NULL
the	NULL
only	NULL
component	NULL
of	NULL
the	NULL
complex	NULL
or	NULL
that	NULL
,	NULL
if	NULL
a	NULL
cofactor	NULL
is	NULL
present	NULL
,	NULL
it	NULL
is	NULL
expressed	NULL
in	NULL
cell	NULL
types	NULL
that	NULL
do	NULL
not	NULL
express	NULL
BCL6	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
results	NULL
demonstrate	NULL
that	NULL
the	NULL
B6BS	NULL
sequence	NULL
can	NULL
serve	NULL
as	NULL
a	NULL
DNA	NULL
target	NULL
site	NULL
for	NULL
in	NULL
vivo	NULL
synthesized	NULL
full-length	NULL
BCL-6	NULL
protein	NULL
.	NULL

BCL6	NULL
Represses	NULL
Transcription	NULL
from	NULL
Promoter	NULL
Linked	NULL
to	NULL
Its	NULL
DNA	NULL
Target	NULL
Site	NULL
.	NULL

To	NULL
investigate	NULL
the	NULL
role	NULL
of	NULL
BCLG	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
transcription	NULL
,	NULL
we	NULL
analyzed	NULL
the	NULL
ability	NULL
of	NULL
a	NULL
BCL6	NULL
expression	NULL
vector	NULL
to	NULL
affect	NULL
the	NULL
transcription	NULL
of	NULL
reporter	NULL
genes	NULL
linked	NULL
to	NULL
a	NULL
promoter	NULL
and	NULL
the	NULL
B6BS	NULL
site	NULL
in	NULL
transient	NULL
transfection	NULL
assays	NULL
in	NULL
Mutu	NULL
III	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
.	NULL

Cotransfection	NULL
of	NULL
the	NULL
BCL6	NULL
expression	NULL
vector	NULL
with	NULL
a	NULL
reporter	NULL
gene	NULL
(	NULL
LUC	NULL
)	NULL
driven	NULL
by	NULL
the	NULL
constitutively	NULL
active	NULL
TK	NULL
promoter	NULL
linked	NULL
downstream	NULL
to	NULL
a	NULL
single-copy	NULL
B6BS	NULL
led	NULL
to	NULL
a	NULL
strong	NULL
(	NULL
90	NULL
%	NULL
using	NULL
1	NULL
pmol	NULL
effector	NULL
plasmid	NULL
)	NULL
and	NULL
dose-dependent	NULL
repression	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

The	NULL
transrepression	NULL
activity	NULL
was	NULL
dependent	NULL
upon	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
(	NULL
6	NULL
C	NULL
&	NULL
>	NULL
5°	NULL
C	NULL
a	NULL
&	NULL
P	NULL
$	NULL
9	NULL
$	NULL
9	NULL
é	NULL
?	NULL

€	NULL
€	NULL
II	NULL
|	NULL
Antiserum	NULL
-	NULL
N7O-6	NULL
Pre	NULL
N7O-6	NULL
Pre	NULL
Cold	NULL
Oligomer	NULL
_-	NULL
-	NULL
+	NULL
-	NULL
-	NULL
+	NULL
a	NULL
A	NULL
BCL6	NULL
-	NULL
»	NULL
*-	NULL
BCL-6	NULL
FiG	NULL
.	NULL

1	NULL
.	NULL

-	NULL
Identification	NULL
of	NULL
DNA-binding	NULL
complexes	NULL
containing	NULL
BCL-6	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
B-cell	NULL
lines	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
Mutu	NULL
I	NULL
(	NULL
subclone	NULL
of	NULL
lymphoma	NULL
line	NULL
,	NULL
Mutu	NULL
BL	NULL
,	NULL
positive	NULL
for	NULL
BCL	NULL
6	NULL
RNA	NULL
and	NULL
protein	NULL
)	NULL
,	NULL
Mutu	NULL
III	NULL
(	NULL
a	NULL
subclone	NULL
of	NULL
Mutu	NULL
BL	NULL
,	NULL
negative	NULL
for	NULL
BCL	NULL
6	NULL
RNA	NULL
and	NULL
protein	NULL
)	NULL
,	NULL
NTera-2	NULL
transfected	NULL
with	NULL
a	NULL
BCL6	NULL
expression	NULL
vector	NULL
(	NULL
NTera-2/BCL-6	NULL
)	NULL
,	NULL
or	NULL
a	NULL
control	NULL
vector	NULL
(	NULL
NTera-2/control	NULL
)	NULL
were	NULL
assayed	NULL
for	NULL
binding	NULL
to	NULL
the	NULL
B6BS	NULL
probe	NULL
by	NULL
EMSA	NULL
.	NULL

Arrows	NULL
point	NULL
to	NULL
BCL-6-containing	NULL
complexes	NULL
.	NULL

Cold	NULL
cognate	NULL
oligomer	NULL
competition	NULL
was	NULL
performed	NULL
using	NULL
a	NULL
10-fold	NULL
excess	NULL
of	NULL
the	NULL
B6BS	NULL
probe	NULL
.	NULL

Supershift	NULL
analysis	NULL
was	NULL
performed	NULL
by	NULL
using	NULL
an	NULL
anti-BCL-6	NULL
(	NULL
N70-6	NULL
)	NULL
antiserum	NULL
recognizing	NULL
the	NULL
N-terminus	NULL
of	NULL
BCL6	NULL
or	NULL
a	NULL
pre-immune	NULL
(	NULL
Pre	NULL
)	NULL
serum	NULL
as	NULL
a	NULL
control	NULL
for	NULL
specificity	NULL
.	NULL

Biochemistry	NULL
:	NULL
Chang	NULL
et	NULL
al	NULL
.	NULL

BCL6	NULL
DNA-binding	NULL
site	NULL
since	NULL
a	NULL
reporter	NULL
plasmid	NULL
(	NULL
TK-LUC	NULL
)	NULL
lacking	NULL
B6BS	NULL
was	NULL
only	NULL
marginally	NULL
affected	NULL
by	NULL
BCL6	NULL
.	NULL

This	NULL
activity	NULL
is	NULL
most	NULL
likely	NULL
due	NULL
to	NULL
nonspecific	NULL
``	NULL
squelching	NULL
``	NULL
since	NULL
it	NULL
is	NULL
detectable	NULL
independently	NULL
of	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
B6BS	NULL
site	NULL
on	NULL
the	NULL
reporter	NULL
gene	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
transrepression	NULL
activity	NULL
of	NULL
BCL6	NULL
was	NULL
also	NULL
dependent	NULL
upon	NULL
the	NULL
presence	NULL
of	NULL
an	NULL
intact	NULL
N-terminal	NULL
half	NULL
of	NULL
the	NULL
protein	NULL
since	NULL
a	NULL
vector	NULL
expressing	NULL
only	NULL
the	NULL
BCLG6G	NULL
ZF	NULL
domain	NULL
retained	NULL
the	NULL
ability	NULL
to	NULL
bind	NULL
DNA	NULL
specifically	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
but	NULL
lost	NULL
the	NULL
ability	NULL
to	NULL
repress	NULL
tran-scription	NULL
.	NULL

Analogous	NULL
results	NULL
were	NULL
obtained	NULL
in	NULL
additional	NULL
non-B	NULL
cell	NULL
lines	NULL
that	NULL
do	NULL
not	NULL
express	NULL
BCL6	NULL
(	NULL
293T	NULL
cells	NULL
)	NULL
,	NULL
while	NULL
transfection	NULL
assays	NULL
performed	NULL
in	NULL
B-cell	NULL
lines	NULL
expressing	NULL
high	NULL
levels	NULL
of	NULL
endogenous	NULL
BCL	NULL
6	NULL
led	NULL
to	NULL
only	NULL
minimal	NULL
levels	NULL
of	NULL
repression	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
BCLG	NULL
is	NULL
a	NULL
site-specific	NULL
transcriptional	NULL
repressor	NULL
and	NULL
suggest	NULL
that	NULL
its	NULL
transrepressive	NULL
activity	NULL
is	NULL
mediated	NULL
by	NULL
its	NULL
N-terminal	NULL
region	NULL
.	NULL

Reporters	NULL
BEBS-TK-LUC	NULL
_	NULL
Lwe	NULL
__	NULL
TK-LUC	NULL
__	NULL
Tk	NULL
]	NULL
Q	NULL
Effectors	NULL
419	NULL
517	NULL
BCL-6	NULL
d	NULL
[	NULL
1-418	NULL
]	NULL
ma	NULL
CGA	NULL
HA	NULL
ZF	NULL
121	NULL
517	NULL
Bols	NULL
Eos	NULL
#	NULL
#	NULL
#	NULL
POZ	NULL
ZF	NULL
B	NULL
R	NULL
sous	NULL
[	NULL
_	NULL
]	NULL
BoL-6	NULL
af1-418	NULL
]	NULL
100	NULL
Relative	NULL
Luciferase	NULL
Activity	NULL
(	NULL
%	NULL
)	NULL
CCGs	NULL
``	NULL
tS	NULL
TK-LUC	NULL
Reporter	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

BCL6	NULL
can	NULL
repress	NULL
transcription	NULL
from	NULL
a	NULL
promoter	NULL
linked	NULL
to	NULL
the	NULL
B6BS	NULL
site	NULL
.	NULL

(	NULL
4	NULL
)	NULL
Schematic	NULL
representation	NULL
of	NULL
the	NULL
reporter	NULL
and	NULL
effector	NULL
vectors	NULL
used	NULL
.	NULL

B6BS	NULL
,	NULL
1	NULL
copy	NULL
of	NULL
the	NULL
B6BS	NULL
20	NULL
bp	NULL
site	NULL
;	NULL
TK	NULL
,	NULL
promoter	NULL
region	NULL
of	NULL
the	NULL
thymidine	NULL
kinase	NULL
gene	NULL
;	NULL
LUC	NULL
,	NULL
coding	NULL
region	NULL
of	NULL
the	NULL
luciferase	NULL
gene	NULL
;	NULL
Ad	NULL
,	NULL
adenovirus	NULL
major	NULL
late	NULL
promoter	NULL
region	NULL
;	NULL
HA	NULL
,	NULL
influenza-hemagglutinin	NULL
epitope	NULL
tag	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Increasing	NULL
amounts	NULL
(	NULL
0	NULL
,	NULL
0.1	NULL
,	NULL
0.3	NULL
,	NULL
1.0	NULL
pmol	NULL
)	NULL
of	NULL
the	NULL
pMT2-BCL-6	NULL
or	NULL
pMT2-BCL-6	NULL
d	NULL
[	NULL
1-418	NULL
]	NULL
effector	NULL
vectors	NULL
were	NULL
cotransfected	NULL
into	NULL
Mutu	NULL
III	NULL
cells	NULL
with	NULL
0.4	NULL
pmol	NULL
of	NULL
target	NULL
plasmid	NULL
(	NULL
pB6BS-TK-LUC	NULL
or	NULL
TK-LUC	NULL
)	NULL
by	NULL
a	NULL
modified	NULL
calcium	NULL
phosphate	NULL
precipitation	NULL
method	NULL
.	NULL

The	NULL
total	NULL
amount	NULL
of	NULL
transfected	NULL
DNA	NULL
and	NULL
vector	NULL
sequences	NULL
was	NULL
kept	NULL
constant	NULL
in	NULL
each	NULL
experiment	NULL
by	NULL
adding	NULL
pMT2	NULL
DNA	NULL
to	NULL
reach	NULL
30	NULL
ug	NULL
.	NULL

Two	NULL
micrograms	NULL
of	NULL
a	NULL
plasmid	NULL
expressing	NULL
the	NULL
bacterial	NULL
B-galactosidase	NULL
gene	NULL
were	NULL
also	NULL
cotransfected	NULL
in	NULL
each	NULL
experiment	NULL
to	NULL
serve	NULL
as	NULL
an	NULL
internal	NULL
control	NULL
for	NULL
transfection	NULL
efficiency	NULL
.	NULL

Forty-eight	NULL
hours	NULL
after	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
harvested	NULL
and	NULL
luciferase	NULL
activity	NULL
was	NULL
measured	NULL
in	NULL
a	NULL
luminometer	NULL
.	NULL

Values	NULL
are	NULL
expressed	NULL
as	NULL
percent	NULL
of	NULL
those	NULL
obtained	NULL
using	NULL
the	NULL
reporter	NULL
vector	NULL
alone	NULL
after	NULL
normalization	NULL
for	NULL
B-galactosidase	NULL
values	NULL
.	NULL

No	NULL
significant	NULL
difference	NULL
was	NULL
detectable	NULL
between	NULL
the	NULL
basal	NULL
levels	NULL
of	NULL
expression	NULL
of	NULL
B6BS-TK-LUC	NULL
and	NULL
TK-LUC	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Experiments	NULL
were	NULL
performed	NULL
in	NULL
triplicate	NULL
and	NULL
error	NULL
bars	NULL
are	NULL
shown	NULL
.	NULL

The	NULL
results	NULL
indicate	NULL
that	NULL
BCL	NULL
6	NULL
expression	NULL
leads	NULL
to	NULL
a	NULL
dose-dependent	NULL
repression	NULL
of	NULL
the	NULL
reporter	NULL
gene	NULL
activity	NULL
and	NULL
that	NULL
BCL6-mediated	NULL
repression	NULL
is	NULL
dependent	NULL
upon	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
N-terminal	NULL
half	NULL
of	NULL
the	NULL
BCL-6	NULL
protein	NULL
and	NULL
the	NULL
B6BS	NULL
site	NULL
on	NULL
the	NULL
reporter	NULL
plasmid	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
93	NULL
(	NULL
1996	NULL
)	NULL
6949	NULL
The	NULL
N-Terminal	NULL
Half	NULL
of	NULL
the	NULL
BCL-6	NULL
Protein	NULL
Is	NULL
Capable	NULL
of	NULL
Autonomous	NULL
Transrepression	NULL
Activity	NULL
.	NULL

To	NULL
conclusively	NULL
determine	NULL
whether	NULL
the	NULL
N-terminal	NULL
region	NULL
of	NULL
BCLG6	NULL
contains	NULL
a	NULL
transrepression	NULL
domain	NULL
and	NULL
whether	NULL
this	NULL
domain	NULL
was	NULL
capable	NULL
of	NULL
acting	NULL
autonomously	NULL
,	NULL
we	NULL
tested	NULL
whether	NULL
the	NULL
BCLG6	NULL
transrepression	NULL
activity	NULL
was	NULL
transferable	NULL
to	NULL
an	NULL
heterologous	NULL
DNA-binding	NULL
domain	NULL
such	NULL
as	NULL
the	NULL
one	NULL
from	NULL
the	NULL
yeast	NULL
Gal4	NULL
transcription	NULL
factor	NULL
.	NULL

We	NULL
constructed	NULL
a	NULL
vector	NULL
[	NULL
GalM-BCL-6	NULL
(	NULL
2-517	NULL
)	NULL
]	NULL
expressing	NULL
a	NULL
fusion	NULL
protein	NULL
in	NULL
which	NULL
the	NULL
non-ZF	NULL
region	NULL
(	NULL
amino	NULL
acids	NULL
2-517	NULL
)	NULL
of	NULL
BCL6	NULL
was	NULL
linked	NULL
to	NULL
the	NULL
Gal4	NULL
DNA	NULL
binding	NULL
domain	NULL
(	NULL
amino	NULL
acids	NULL
1-147	NULL
)	NULL
and	NULL
cotransfected	NULL
it	NULL
(	NULL
293T	NULL
cells	NULL
)	NULL
with	NULL
a	NULL
reporter	NULL
gene	NULL
construct	NULL
(	NULL
GS-TK-LUC	NULL
)	NULL
driven	NULL
by	NULL
the	NULL
TK	NULL
promoter	NULL
region	NULL
linked	NULL
to	NULL
Gal4	NULL
binding	NULL
sites	NULL
(	NULL
G5	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
)	NULL
.	NULL

The	NULL
results	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
indicate	NULL
that	NULL
the	NULL
Gal4-BCL-6	NULL
[	NULL
2-517	NULL
]	NULL
fusion	NULL
protein	NULL
is	NULL
capable	NULL
of	NULL
strong	NULL
(	NULL
90	NULL
%	NULL
repression	NULL
obtained	NULL
with	NULL
0.1	NULL
pmol	NULL
Gald4-BCL-6	NULL
vector	NULL
)	NULL
and	NULL
dose-dependent	NULL
repression	NULL
of	NULL
reporter	NULL
gene	NULL
expres-sion	NULL
.	NULL

The	NULL
observed	NULL
activity	NULL
is	NULL
specific	NULL
since	NULL
it	NULL
is	NULL
dependent	NULL
upon	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
BCLG	NULL
domain	NULL
in	NULL
the	NULL
effector	NULL
vector	NULL
(	NULL
see	NULL
modest	NULL
activity	NULL
of	NULL
Gald4	NULL
vector	NULL
)	NULL
and	NULL
the	NULL
Gal4	NULL
DNA	NULL
binding	NULL
site	NULL
in	NULL
the	NULL
reporter	NULL
vector	NULL
(	NULL
see	NULL
modest	NULL
repression	NULL
of	NULL
the	NULL
TK-LUC	NULL
reporter	NULL
gene	NULL
)	NULL
.	NULL

Analogous	NULL
experiments	NULL
performed	NULL
using	NULL
reporter	NULL
genes	NULL
driven	NULL
by	NULL
minimal	NULL
promoters	NULL
(	NULL
E1B	NULL
,	NULL
SV40	NULL
)	NULL
lead	NULL
to	NULL
some	NULL
degree	NULL
of	NULL
repression	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
the	NULL
specificity	NULL
of	NULL
which	NULL
,	NULL
however	NULL
,	NULL
was	NULL
difficult	NULL
to	NULL
establish	NULL
due	NULL
to	NULL
the	NULL
low	NULL
basal	NULL
activity	NULL
of	NULL
these	NULL
promoters	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
N-terminal	NULL
domain	NULL
of	NULL
BCL6	NULL
(	NULL
amino	NULL
acids	NULL
2-517	NULL
)	NULL
contains	NULL
a	NULL
potent	NULL
autonomous	NULL
transrepression	NULL
domain	NULL
.	NULL

Reporters	NULL
as	NULL
G5-TK-LUC	NULL
a	NULL
TK	NULL
Epe	NULL
-+	NULL
Tk-LUC	NULL
Tk	NULL
Luc	NULL
__|	NULL
Effectors	NULL
Gald-	NULL
GV-	NULL
{	NULL
___	NULL
}	NULL
Gald	NULL
12	NULL
‘	NULL
1	NULL
517	NULL
cascls	NULL
(	NULL
sim	NULL
)	NULL
-	NULL
g_	NULL
}	NULL
Haar	NULL
,	NULL
2	NULL
Gald	NULL
POZ	NULL
B	NULL
R	NULL
cais-Bcu-6	NULL
(	NULL
2-517	NULL
)	NULL
>	NULL
J	NULL
[	NULL
_	NULL
]	NULL
Ga-|	NULL
|	NULL
|	NULL
|	NULL
Relative	NULL
Luciferase	NULL
Activity	NULL
(	NULL
%	NULL
)	NULL
Effector	NULL
em-	NULL
[	NULL
r	NULL
?	NULL

D	NULL
GsTk-LUC	NULL
TK-LUC	NULL
R	NULL
&	NULL
PONgy	NULL
==	NULL
--	NULL
teen	NULL
__	NULL
TkLUC__	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

The	NULL
N-terminal	NULL
half	NULL
of	NULL
BCLG6	NULL
contains	NULL
an	NULL
autonomous	NULL
transrepression	NULL
domain	NULL
.	NULL

(	NULL
4	NULL
)	NULL
Schematic	NULL
representation	NULL
of	NULL
reporter	NULL
and	NULL
effector	NULL
vectors	NULL
used	NULL
.	NULL

G5	NULL
,	NULL
five	NULL
copies	NULL
of	NULL
the	NULL
Gal4	NULL
binding	NULL
site	NULL
(	NULL
32	NULL
)	NULL
;	NULL
SV	NULL
,	NULL
SV-40	NULL
promoter-enhancer	NULL
region	NULL
;	NULL
other	NULL
abbreviations	NULL
are	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

24	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Increasing	NULL
amounts	NULL
(	NULL
0	NULL
,	NULL
0.001	NULL
,	NULL
0.003	NULL
,	NULL
0.01	NULL
,	NULL
0.03	NULL
,	NULL
0.1	NULL
,	NULL
and	NULL
0.3	NULL
pmo	NULL
!	NULL
)	NULL

of	NULL
the	NULL
Gal4-BCL-6	NULL
(	NULL
2-517	NULL
)	NULL
or	NULL
Gal4	NULL
effector	NULL
vector	NULL
were	NULL
cotransfected	NULL
with	NULL
2	NULL
ug	NULL
of	NULL
the	NULL
GS-TK-LUC	NULL
or	NULL
TK-LUC	NULL
and	NULL
2	NULL
ug	NULL
SV-B-galactosidase	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
into	NULL
293T	NULL
cells	NULL
.	NULL

Values	NULL
are	NULL
expressed	NULL
and	NULL
normalized	NULL
as	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

6950	NULL
Biochemistry	NULL
:	NULL
Chang	NULL
et	NULL
al	NULL
.	NULL

The	NULL
Transrepression	NULL
Activity	NULL
of	NULL
BCL6	NULL
is	NULL
Position-	NULL
,	NULL
Orien-tation-	NULL
,	NULL
and	NULL
Distance-Independent	NULL
.	NULL

To	NULL
characterize	NULL
further	NULL
the	NULL
transrepression	NULL
activity	NULL
of	NULL
BCL6	NULL
,	NULL
we	NULL
investigated	NULL
the	NULL
effects	NULL
of	NULL
varying	NULL
the	NULL
distance	NULL
,	NULL
5'-3	NULL
'	NULL
position	NULL
and	NULL
orientation	NULL
between	NULL
the	NULL
DNA	NULL
binding	NULL
site	NULL
and	NULL
the	NULL
promoter	NULL
of	NULL
the	NULL
reporter	NULL
gene	NULL
.	NULL

Toward	NULL
this	NULL
end	NULL
,	NULL
the	NULL
Gal4-BCL-6	NULL
[	NULL
2-517	NULL
]	NULL
vector	NULL
was	NULL
cotransfected	NULL
into	NULL
293T	NULL
cells	NULL
with	NULL
various	NULL
constructs	NULL
in	NULL
which	NULL
the	NULL
Gal4	NULL
binding	NULL
site	NULL
was	NULL
positioned	NULL
at	NULL
variable	NULL
distance	NULL
5	NULL
'	NULL
[	NULL
750	NULL
bp	NULL
:	NULL
G5	NULL
(	NULL
-750	NULL
)	NULL
-TK	NULL
CAT	NULL
;	NULL
110	NULL
bp	NULL
:	NULL
G5	NULL
(	NULL
-110	NULL
)	NULL
-TK	NULL
CAT	NULL
]	NULL
,	NULL
or	NULL
3	NULL
'	NULL
[	NULL
GS	NULL
(	NULL
+1000	NULL
)	NULL
SV-CAT	NULL
]	NULL
,	NULL
or	NULL
at	NULL
opposite	NULL
orientations	NULL
(	NULL
GS5-SVCAT	NULL
versus	NULL
GS-SV'CAT	NULL
)	NULL
with	NULL
respect	NULL
to	NULL
the	NULL
promoters	NULL
(	NULL
TK	NULL
or	NULL
SV40	NULL
)	NULL
driving	NULL
the	NULL
CAT	NULL
reporter	NULL
gene	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

The	NULL
results	NULL
show	NULL
that	NULL
the	NULL
transrepression	NULL
activity	NULL
was	NULL
maintained	NULL
on	NULL
all	NULL
reporter	NULL
constructs	NULL
tested	NULL
.	NULL

Thus	NULL
,	NULL
BCL6-mediated	NULL
transrepression	NULL
can	NULL
act	NULL
on	NULL
DNA	NULL
binding	NULL
sites	NULL
independently	NULL
of	NULL
their	NULL
position	NULL
(	NULL
3	NULL
'	NULL
versus	NULL
5	NULL
``	NULL
)	NULL
,	NULL
orientation	NULL
and	NULL
distance	NULL
from	NULL
the	NULL
promoter	NULL
of	NULL
the	NULL
target	NULL
gene	NULL
.	NULL

Mapping	NULL
of	NULL
the	NULL
BCL6	NULL
Transrepression	NULL
Domain	NULL
.	NULL

To	NULL
determine	NULL
which	NULL
region	NULL
within	NULL
the	NULL
N-terminal	NULL
half	NULL
(	NULL
amino	NULL
acids	NULL
2-517	NULL
)	NULL
of	NULL
BCL6	NULL
was	NULL
responsible	NULL
for	NULL
the	NULL
transcriptional	NULL
repression	NULL
activity	NULL
,	NULL
we	NULL
constructed	NULL
various	NULL
deletion	NULL
mutants	NULL
of	NULL
the	NULL
BCL6	NULL
portion	NULL
of	NULL
the	NULL
Gal4-BCL-6	NULL
[	NULL
2-517	NULL
]	NULL
vector	NULL
(	NULL
Fig	NULL
.	NULL

54	NULL
)	NULL
and	NULL
tested	NULL
their	NULL
ability	NULL
to	NULL
repress	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
GS-TK-LUC	NULL
reporter	NULL
gene	NULL
in	NULL
cotransfection	NULL
experiments	NULL
in	NULL
293T	NULL
and	NULL
in	NULL
NIH	NULL
373	NULL
cells	NULL
.	NULL

In	NULL
both	NULL
cell	NULL
lines	NULL
,	NULL
significant	NULL
loss	NULL
of	NULL
activity	NULL
was	NULL
associated	NULL
with	NULL
mutants	NULL
lacking	NULL
a	NULL
relatively	NULL
central	NULL
domain	NULL
of	NULL
the	NULL
BCL6	NULL
molecule	NULL
(	NULL
amino	NULL
acids	NULL
267-395	NULL
)	NULL
(	NULL
see	NULL
mutant	NULL
C	NULL
versus	NULL
D	NULL
)	NULL
,	NULL
part	NULL
of	NULL
the	NULL
POZ	NULL
domain	NULL
(	NULL
F	NULL
,	NULL
G	NULL
,	NULL
H	NULL
,	NULL
and	NULL
L	NULL
)	NULL
,	NULL
or	NULL
both	NULL
(	NULL
I	NULL
)	NULL
.	NULL

In	NULL
both	NULL
cell	NULL
lines	NULL
,	NULL
maximal	NULL
levels	NULL
of	NULL
transrepression	NULL
activity	NULL
(	NULL
>	NULL
95	NULL
%	NULL
)	NULL
,	NULL
comparable	NULL
to	NULL
those	NULL
obtained	NULL
with	NULL
Gald4-BCL-6	NULL
[	NULL
2-517	NULL
]	NULL
,	NULL
were	NULL
obtained	NULL
only	NULL
in	NULL
those	NULL
mutants	NULL
that	NULL
retained	NULL
these	NULL
two	NULL
domains	NULL
,	NULL
while	NULL
deletion	NULL
of	NULL
variable	NULL
portions	NULL
between	NULL
them	NULL
was	NULL
functionally	NULL
irrelevant	NULL
(	NULL
J	NULL
and	NULL
K	NULL
)	NULL
.	NULL

Accordingly	NULL
,	NULL
the	NULL
presence	NULL
of	NULL
only	NULL
one	NULL
of	NULL
the	NULL
two	NULL
domains	NULL
(	NULL
POZ	NULL
in	NULL
E	NULL
;	NULL
amino	NULL
acids	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
93	NULL
(	NULL
1996	NULL
)	NULL
267-395	NULL
in	NULL
F	NULL
)	NULL
was	NULL
insufficient	NULL
to	NULL
confer	NULL
maximal	NULL
transrepression	NULL
activity	NULL
.	NULL

The	NULL
observed	NULL
reduction	NULL
in	NULL
reporter	NULL
gene	NULL
activity	NULL
was	NULL
not	NULL
the	NULL
result	NULL
of	NULL
differences	NULL
in	NULL
transfection	NULL
or	NULL
expression	NULL
efficiencies	NULL
among	NULL
the	NULL
various	NULL
effector	NULL
constructs	NULL
since	NULL
immunoprecipitation	NULL
analysis	NULL
of	NULL
transfected	NULL
cells	NULL
indicated	NULL
comparable	NULL
levels	NULL
of	NULL
expression	NULL
for	NULL
all	NULL
Gal4-BCL-6	NULL
fusion	NULL
proteins	NULL
(	NULL
representative	NULL
results	NULL
in	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

The	NULL
observed	NULL
results	NULL
were	NULL
not	NULL
due	NULL
to	NULL
differences	NULL
in	NULL
subcellular	NULL
localization	NULL
or	NULL
DNA	NULL
binding	NULL
among	NULL
the	NULL
various	NULL
proteins	NULL
since	NULL
comparable	NULL
levels	NULL
of	NULL
specific	NULL
DNA	NULL
binding	NULL
were	NULL
observed	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
transfected	NULL
cells	NULL
by	NULL
EMSA	NULL
using	NULL
as	NULL
a	NULL
probe	NULL
a	NULL
synthetic	NULL
oligonucleotide	NULL
corresponding	NULL
to	NULL
the	NULL
Gal4	NULL
binding	NULL
site	NULL
(	NULL
representative	NULL
results	NULL
are	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5C	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
these	NULL
results	NULL
indicate	NULL
that	NULL
two	NULL
noncontiguous	NULL
domains	NULL
,	NULL
corresponding	NULL
to	NULL
POZ	NULL
(	NULL
amino	NULL
acids	NULL
11-121	NULL
)	NULL
and	NULL
to	NULL
amino	NULL
acids	NULL
267-395	NULL
,	NULL
are	NULL
necessary	NULL
for	NULL
maximal	NULL
transrepression	NULL
by	NULL
BCL6	NULL
.	NULL

DISCUSSION	NULL
Based	NULL
on	NULL
the	NULL
presence	NULL
of	NULL
ZF	NULL
motifs	NULL
and	NULL
a	NULL
N-terminal	NULL
POZ	NULL
domain	NULL
,	NULL
previous	NULL
studies	NULL
have	NULL
suggested	NULL
that	NULL
the	NULL
BCL-6	NULL
protein	NULL
may	NULL
function	NULL
as	NULL
a	NULL
DNA-binding	NULL
transcription	NULL
factor	NULL
(	NULL
2	NULL
,	NULL
4	NULL
,	NULL
5	NULL
)	NULL
.	NULL

The	NULL
present	NULL
study	NULL
demonstrates	NULL
that	NULL
nuclear	NULL
extracts	NULL
from	NULL
B-cell	NULL
lines	NULL
contain	NULL
protein	NULL
complexes	NULL
in	NULL
which	NULL
BCL-6	NULL
binds	NULL
DNA	NULL
at	NULL
it	NULL
specific	NULL
target	NULL
sequence	NULL
and	NULL
that	NULL
BCLG6	NULL
can	NULL
repress	NULL
transcription	NULL
from	NULL
promoters	NULL
linked	NULL
to	NULL
the	NULL
same	NULL
DNA	NULL
target	NULL
site	NULL
.	NULL

These	NULL
results	NULL
have	NULL
implications	NULL
for	NULL
the	NULL
function	NULL
of	NULL
BCL-6	NULL
and	NULL
other	NULL
POZ	NULL
/zinc	NULL
finger	NULL
proteins	NULL
as	NULL
well	NULL
as	NULL
for	NULL
the	NULL
role	NULL
of	NULL
BCL	NULL
6	NULL
in	NULL
normal	NULL
and	NULL
neoplastic	NULL
lymphoid	NULL
development	NULL
.	NULL

DNA-Binding	NULL
Complexes	NULL
Containing	NULL
BCL-6	NULL
in	NULL
B	NULL
Cells	NULL
.	NULL

Two	NULL
previous	NULL
studies	NULL
have	NULL
identified	NULL
DNA	NULL
consensus	NULL
sequences	NULL
capable	NULL
of	NULL
binding	NULL
purified	NULL
recombinant	NULL
BCL-6	NULL
in	NULL
vitro	NULL
(	NULL
15	NULL
,	NULL
16	NULL
)	NULL
.	NULL

One	NULL
of	NULL
this	NULL
candidate	NULL
sites	NULL
was	NULL
also	NULL
shown	NULL
to	NULL
bind	NULL
protein	NULL
complex	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
cells	NULL
expressing	NULL
BCL	NULL
6	NULL
,	NULL
but	NULL
the	NULL
%	NULL
Conversion	NULL
Fold	NULL
Repression	NULL
Reporters	NULL
Effectors	NULL
GSTK	NULL
CAT	NULL
Gal4	NULL
mal__cat	NULL
_|	NULL
Gal4-BCL-6	NULL
(	NULL
2-517	NULL
)	NULL
GS5	NULL
(	NULL
+1000	NULL
)	NULL
TK	NULL
CAT	NULL
Lod	NULL
Gal4	NULL
Gal4-BCL-6	NULL
(	NULL
2-517	NULL
)	NULL
Gal4	NULL
Gald4-BCL-6	NULL
(	NULL
2-517	NULL
)	NULL
Gal4	NULL
Gal4-BCL-6	NULL
(	NULL
2-517	NULL
)	NULL
Gal4	NULL
GSSV	NULL
'	NULL
CAT	NULL
-g	NULL
»	NULL
wl	NULL
car	NULL
_|	NULL
Gal4-BCL-6	NULL
(	NULL
2-517	NULL
)	NULL
GS	NULL
(	NULL
110	NULL
)	NULL
SV	NULL
CAT	NULL
lsy|	NULL
_	NULL
cat	NULL
_|	NULL
Gal4	NULL
Gal4-BCL-6	NULL
(	NULL
2-517	NULL
)	NULL
#	NULL
‘	NULL
98.4+/-14.1	NULL
%	NULL
13.3	NULL
7.4+/-2.1	NULL
%	NULL
U	NULL
12.2+/-0.4	NULL
%	NULL
8.3	NULL
1.5+/-1.2	NULL
%	NULL
[	NULL
.	NULL

50.9+/-6.5	NULL
%	NULL
7.4	NULL
6.9+/-0.1	NULL
%	NULL
E	NULL
t	NULL
69.2+/-13:0	NULL
%	NULL
f	NULL
22.7	NULL
3.1+/-0.2	NULL
%	NULL
&	NULL
t	NULL
98.0+/-0.3	NULL
%	NULL
20.8	NULL
4.7+/-1.3	NULL
%	NULL
28.3+/-4.5	NULL
%	NULL
35.7	NULL
0.8+/-0.3	NULL
%	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

Position	NULL
,	NULL
distance-	NULL
,	NULL
and	NULL
orientiation-independent	NULL
transcriptional	NULL
repression	NULL
by	NULL
Gal4-BCL-6	NULL
fusion	NULL
proteins	NULL
.	NULL

293T	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
0.1	NULL
pmol	NULL
Gal4-BCL-6	NULL
(	NULL
2-517	NULL
)	NULL
,	NULL
1	NULL
ug	NULL
SV-B-galactosidase	NULL
plasmid	NULL
,	NULL
and	NULL
2	NULL
ug	NULL
of	NULL
various	NULL
reporter	NULL
plasmids	NULL
(	NULL
CAT	NULL
and	NULL
SV-40	NULL
promoter	NULL
region	NULL
)	NULL
as	NULL
described	NULL
in	NULL
Figs	NULL
.	NULL

2	NULL
and	NULL
3	NULL
.	NULL

CAT	NULL
activity	NULL
was	NULL
measured	NULL
48	NULL
hr	NULL
after	NULL
transfection	NULL
by	NULL
thin	NULL
layer	NULL
chromatography	NULL
.	NULL

A	NULL
representative	NULL
chromatogram	NULL
showing	NULL
the	NULL
results	NULL
obtained	NULL
with	NULL
each	NULL
vector	NULL
combination	NULL
is	NULL
shown	NULL
.	NULL

Values	NULL
are	NULL
expressed	NULL
as	NULL
percent	NULL
conversion	NULL
of	NULL
chloramphenicol	NULL
and	NULL
as	NULL
fold-repression	NULL
obtained	NULL
by	NULL
Gal4-BCL-6	NULL
versus	NULL
Gal4	NULL
vector	NULL
with	NULL
each	NULL
reporter	NULL
vector	NULL
.	NULL

The	NULL
results	NULL
indicate	NULL
that	NULL
comparable	NULL
levels	NULL
of	NULL
repression	NULL
are	NULL
induced	NULL
by	NULL
BCL6	NULL
on	NULL
the	NULL
TK	NULL
(	NULL
7.4-13.3	NULL
fold	NULL
)	NULL
or	NULL
SV	NULL
(	NULL
20.8-35.7	NULL
)	NULL
promoters	NULL
regardless	NULL
of	NULL
the	NULL
position	NULL
(	NULL
3	NULL
'	NULL
or	NULL
5	NULL
'	NULL
)	NULL
,	NULL
orientation	NULL
and	NULL
distance	NULL
of	NULL
the	NULL
Gal4	NULL
DNA-binding	NULL
site	NULL
from	NULL
the	NULL
promoter	NULL
.	NULL

Biochemistry	NULL
:	NULL
Chang	NULL
et	NULL
al	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
93	NULL
(	NULL
1996	NULL
)	NULL
6951	NULL
A	NULL
121	NULL
240	NULL
395	NULL
_	NULL
BCl6	NULL
-	NULL
777/77	NULL
.	NULL

Pos	NULL
Relative	NULL
Luciferase	NULL
Activity	NULL
(	NULL
%	NULL
)	NULL
caq-ran	NULL
-	NULL
£998	NULL
.	NULL

tiie	NULL
Grae	NULL
perm	NULL
iam	NULL
nnn	NULL
getn	NULL
Ae	NULL
ol	NULL
o	NULL
A	NULL
C	NULL
~~~	NULL
.	NULL

—w	NULL
I	NULL
13.3	NULL
B	NULL
|___	NULL
.	NULL

4	NULL
promo	NULL
Pics	NULL
ye	NULL
oy	NULL
fry	NULL
pm	NULL
BUP	NULL
14.1	NULL
msr	NULL
:	NULL
o	NULL
-means	NULL
1111111114	NULL
©	NULL
:	NULL
.	NULL

hag	NULL
p	NULL
L_	NULL
}	NULL
aaa	NULL
///	NULL
]	NULL
7	NULL
)	NULL
121	NULL
E	NULL
[	NULL
___	NULL
___	NULL
]	NULL
122	NULL
FC	NULL
fre	NULL
s	NULL
57	NULL
a	NULL
[	NULL
d	NULL
Z	NULL
ZZZ	NULL
57	NULL
395	NULL
H	NULL
|	NULL
-~	NULL
,	NULL
a	NULL
~ien	NULL
,	NULL
s	NULL
1	NULL
n	NULL
a	NULL
/Z	NULL
136	NULL
176	NULL
395	NULL
J	NULL
LZ	NULL
H	NULL
ZZ	NULL
ZIP	NULL
A	NULL
_	NULL
196	NULL
240	NULL
395	NULL
K	NULL
___	NULL
}	NULL
Z	NULL
83	NULL
176	NULL
395	NULL
L	NULL
|	NULL
gans	NULL
LL	NULL
L	NULL
)	NULL
B	NULL
C	NULL
Gal4-BCL-6	NULL
(	NULL
2-517	NULL
)	NULL
Gal4-BCL-6	NULL
(	NULL
2-395	NULL
)	NULL
Gal4-BCL-6	NULL
(	NULL
2-267	NULL
)	NULL
Hransigction	NULL
Cold	NULL
Oligomers	NULL
|	NULL
Gal4-BCL-6	NULL
(	NULL
57-267	NULL
)	NULL
Gal4-BCL-6	NULL
(	NULL
122-517	NULL
)	NULL
Gal4-BCL-6	NULL
(	NULL
57-395	NULL
)	NULL
Gal4-BCL-6	NULL
(	NULL
57-517	NULL
)	NULL
Gal4-BCL-6	NULL
(	NULL
2-395	NULL
af137-175	NULL
]	NULL
)	NULL
=	NULL
--	NULL
Gal4-BCL-6	NULL
Gal4-BCL-6	NULL
(	NULL
2-395	NULL
a	NULL
[	NULL
137-239	NULL
}	NULL
)	NULL
--	NULL
Gal4	NULL
--	NULL
-	NULL
NS	NULL
O	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

Mapping	NULL
of	NULL
the	NULL
BCL6	NULL
transrepression	NULL
domain	NULL
to	NULL
two	NULL
noncontiguous	NULL
regions	NULL
in	NULL
the	NULL
N-terminal	NULL
half	NULL
of	NULL
BCL6	NULL
.	NULL

(	NULL
4	NULL
)	NULL
Schematic	NULL
representation	NULL
of	NULL
Gal4-BCL-6	NULL
deletion	NULL
mutant	NULL
vectors	NULL
(	NULL
Right	NULL
;	NULL
compare	NULL
with	NULL
schematic	NULL
representation	NULL
of	NULL
the	NULL
BCL-6	NULL
protein	NULL
on	NULL
top	NULL
)	NULL
and	NULL
their	NULL
activity	NULL
in	NULL
repressing	NULL
transcription	NULL
from	NULL
a	NULL
cotransfected	NULL
GS5-TK	NULL
LUC	NULL
reporter	NULL
vector	NULL
(	NULL
assayed	NULL
as	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
in	NULL
293	NULL
and	NULL
3T3	NULL
cells	NULL
(	NULL
Left	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Immunoprecipitation	NULL
analysis	NULL
of	NULL
Gal4-	NULL
and	NULL
Gal4-BCL-6	NULL
fusion	NULL
proteins	NULL
expressed	NULL
in	NULL
transfected	NULL
293T	NULL
cells	NULL
.	NULL

Anti-Gald4	NULL
antiserum	NULL
was	NULL
used	NULL
to	NULL
immunoprecipitate	NULL
[	NULL
*S	NULL
)	NULL
methionine-labeled	NULL
proteins	NULL
that	NULL
were	NULL
resolved	NULL
in	NULL
10	NULL
%	NULL
SDS/PAGE	NULL
.	NULL

Bands	NULL
corresponding	NULL
to	NULL
Gal4-BCL-6	NULL
fusion	NULL
proteins	NULL
are	NULL
indicated	NULL
by	NULL
open	NULL
circles	NULL
.	NULL

Proteins	NULL
with	NULL
molecular	NULL
mass	NULL
smaller	NULL
than	NULL
that	NULL
predicted	NULL
for	NULL
the	NULL
corresponding	NULL
fusion	NULL
protein	NULL
represent	NULL
partial	NULL
degradation	NULL
products	NULL
.	NULL

Only	NULL
representative	NULL
data	NULL
are	NULL
shown	NULL
since	NULL
different	NULL
fusion	NULL
proteins	NULL
required	NULL
different	NULL
gels	NULL
for	NULL
analysis	NULL
.	NULL

The	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
transfected	NULL
constructs	NULL
express	NULL
the	NULL
Gald4-BCL-6	NULL
proteins	NULL
at	NULL
comparable	NULL
levels	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Gal4-BCL-6	NULL
deletion	NULL
mutants	NULL
retain	NULL
the	NULL
ability	NULL
to	NULL
bind	NULL
DNA	NULL
.	NULL

Nuclear	NULL
extracts	NULL
of	NULL
293T	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
Gal4-BCL-6	NULL
(	NULL
2-395	NULL
)	NULL
,	NULL
Gal4-BCL-6	NULL
(	NULL
57-517	NULL
)	NULL
,	NULL
Gald4	NULL
vectors	NULL
or	NULL
mock-transfected	NULL
(	NULL
Mock	NULL
)	NULL
were	NULL
analyzed	NULL
by	NULL
EMSA	NULL
using	NULL
as	NULL
a	NULL
probe	NULL
a	NULL
27-bp	NULL
oligomer	NULL
containing	NULL
the	NULL
Gal4	NULL
DNA-binding	NULL
site	NULL
(	NULL
CGGAAGACTCTCCTCCG	NULL
;	NULL
ref	NULL
.	NULL

32	NULL
)	NULL
.	NULL

Flfty	NULL
fold	NULL
cold	NULL
cognate	NULL
oligomer	NULL
was	NULL
used	NULL
in	NULL
the	NULL
assay	NULL
to	NULL
control	NULL
for	NULL
specificity	NULL
.	NULL

NS	NULL
,	NULL
nonspecific	NULL
band	NULL
.	NULL

The	NULL
results	NULL
indicate	NULL
that	NULL
Gal4-BCL-	NULL
6	NULL
(	NULL
2—395	NULL
)	NULL
(	NULL
active	NULL
in	NULL
transrepression	NULL
;	NULL
see	NULL
4	NULL
)	NULL
and	NULL
Gal4-BCL-6	NULL
(	NULL
57-517	NULL
)	NULL
(	NULL
inactive	NULL
)	NULL
display	NULL
comparable	NULL
DNA-binding	NULL
activities	NULL
.	NULL

presence	NULL
of	NULL
BCL-6	NULL
within	NULL
in	NULL
vivo	NULL
formed	NULL
DNA-binding	NULL
com-	NULL
specific	NULL
immunodetection	NULL
of	NULL
BCL-6	NULL
in	NULL
DNA	NULL
binding	NULL
assays	NULL
,	NULL
we	NULL
plexes	NULL
could	NULL
not	NULL
be	NULL
demonstrated	NULL
(	NULL
16	NULL
)	NULL
.	NULL

Using	NULL
a	NULL
target	NULL
DNA	NULL
provide	NULL
direct	NULL
evidence	NULL
for	NULL
the	NULL
presence	NULL
of	NULL
BCL-6	NULL
within	NULL
natu-sequence	NULL
optimized	NULL
for	NULL
in	NULL
vifro	NULL
binding	NULL
to	NULL
BCL-6	NULL
as	NULL
well	NULL
as	NULL
rally	NULL
occurring	NULL
complexes	NULL
in	NULL
various	NULL
B-cell	NULL
types	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

This	NULL
6952	NULL
Biochemistry	NULL
:	NULL
Chang	NULL
et	NULL
al	NULL
.	NULL

result	NULL
validates	NULL
the	NULL
B6BS	NULL
site	NULL
as	NULL
the	NULL
best	NULL
target	NULL
for	NULL
BCL6	NULL
in	NULL
vitro	NULL
and	NULL
suggest	NULL
that	NULL
this	NULL
site	NULL
may	NULL
represent	NULL
the	NULL
target	NULL
for	NULL
BCL6G	NULL
binding	NULL
in	NULL
vivo	NULL
.	NULL

Our	NULL
results	NULL
also	NULL
demonstrate	NULL
that	NULL
BCL-6	NULL
contacts	NULL
DNA	NULL
as	NULL
a	NULL
full-length	NULL
protein	NULL
in	NULL
in	NULL
vivo	NULL
formed	NULL
protein	NULL
complexes	NULL
.	NULL

This	NULL
finding	NULL
is	NULL
relevant	NULL
in	NULL
view	NULL
of	NULL
the	NULL
observation	NULL
that	NULL
another	NULL
POZ	NULL
/zinc	NULL
finger	NULL
protein	NULL
,	NULL
ZID	NULL
,	NULL
can	NULL
not	NULL
bind	NULL
DNA	NULL
as	NULL
a	NULL
full-length	NULL
protein	NULL
and	NULL
that	NULL
binding-inhibition	NULL
is	NULL
mediated	NULL
by	NULL
the	NULL
POZ	NULL
domain	NULL
(	NULL
19	NULL
)	NULL
.	NULL

Our	NULL
results	NULL
exclude	NULL
the	NULL
possibility	NULL
that	NULL
BCL-6	NULL
can	NULL
only	NULL
bind	NULL
DNA	NULL
in	NULL
a	NULL
processed	NULL
form	NULL
lacking	NULL
the	NULL
POZ	NULL
domain	NULL
(	NULL
19	NULL
)	NULL
,	NULL
but	NULL
leave	NULL
open	NULL
the	NULL
possibility	NULL
that	NULL
other	NULL
proteins	NULL
may	NULL
be	NULL
present	NULL
in	NULL
the	NULL
complex	NULL
and	NULL
necessary	NULL
for	NULL
DNA	NULL
binding	NULL
by	NULL
BCL-6	NULL
.	NULL

The	NULL
finding	NULL
of	NULL
apparently	NULL
identical	NULL
complexes	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
cell	NULL
types	NULL
either	NULL
expressing	NULL
endogenous	NULL
or	NULL
exogenous	NULL
BCL6	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
would	NULL
suggest	NULL
that	NULL
,	NULL
if	NULL
a	NULL
partner	NULL
protein	NULL
is	NULL
present	NULL
,	NULL
it	NULL
is	NULL
widely	NULL
expressed	NULL
in	NULL
various	NULL
tissue	NULL
types	NULL
.	NULL

Transcriptional	NULL
Repression	NULL
by	NULL
BCL6	NULL
.	NULL

Our	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
BCL-6	NULL
protein	NULL
can	NULL
function	NULL
as	NULL
a	NULL
strong	NULL
transcriptional	NULL
repressor	NULL
.	NULL

Although	NULL
variable	NULL
in	NULL
potency	NULL
,	NULL
transrepressor	NULL
functions	NULL
have	NULL
been	NULL
proposed	NULL
for	NULL
other	NULL
POZ/ZF	NULL
proteins	NULL
including	NULL
the	NULL
B	NULL
isoform	NULL
of	NULL
the	NULL
yFBP	NULL
(	NULL
33	NULL
)	NULL
,	NULL
and	NULL
the	NULL
ZF5	NULL
(	NULL
17	NULL
)	NULL
and	NULL
PLZF	NULL
proteins	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Although	NULL
it	NULL
remains	NULL
possible	NULL
that	NULL
,	NULL
similarly	NULL
to	NULL
other	NULL
ZF	NULL
proteins	NULL
,	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
POZ/ZF	NULL
proteins	NULL
may	NULL
be	NULL
dependent	NULL
on	NULL
the	NULL
cellular	NULL
environment	NULL
and	NULL
may	NULL
include	NULL
the	NULL
ability	NULL
of	NULL
transactivate	NULL
,	NULL
all	NULL
POZ/ZF	NULL
proteins	NULL
studied	NULL
so	NULL
far	NULL
have	NULL
displayed	NULL
a	NULL
consistent	NULL
transrepressive	NULL
activity	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
cell	NULL
types	NULL
and	NULL
on	NULL
various	NULL
promoters	NULL
,	NULL
suggesting	NULL
that	NULL
site-specific	NULL
transrepression	NULL
may	NULL
represent	NULL
the	NULL
critical	NULL
function	NULL
of	NULL
these	NULL
family	NULL
of	NULL
nuclear	NULL
factors	NULL
.	NULL

During	NULL
the	NULL
preparation	NULL
of	NULL
this	NULL
manuscript	NULL
,	NULL
analogous	NULL
results	NULL
on	NULL
the	NULL
transrepressive	NULL
activity	NULL
of	NULL
BCLG	NULL
have	NULL
also	NULL
been	NULL
reported	NULL
by	NULL
others	NULL
(	NULL
34	NULL
)	NULL
.	NULL

The	NULL
mechanism	NULL
by	NULL
which	NULL
transrepression	NULL
occurs	NULL
remains	NULL
to	NULL
be	NULL
elucidated	NULL
.	NULL

Our	NULL
results	NULL
suggest	NULL
that	NULL
two	NULL
noncontiguous	NULL
domains	NULL
are	NULL
necessary	NULL
for	NULL
maximal	NULL
transrepressive	NULL
activity	NULL
of	NULL
BCL6	NULL
and	NULL
a	NULL
similar	NULL
conclusion	NULL
has	NULL
been	NULL
recently	NULL
reached	NULL
for	NULL
the	NULL
highly	NULL
homologous	NULL
PLZF	NULL
protein	NULL
(	NULL
J.	NULL
Licht	NULL
,	NULL
personal	NULL
communication	NULL
)	NULL
.	NULL

The	NULL
first	NULL
domain	NULL
virtually	NULL
coincides	NULL
with	NULL
POZ	NULL
sequences	NULL
,	NULL
an	NULL
evolutionarily	NULL
conserved	NULL
motif	NULL
that	NULL
has	NULL
been	NULL
proposed	NULL
to	NULL
mediate	NULL
protein-protein	NULL
interactions	NULL
in	NULL
large	NULL
multimeric	NULL
complexes	NULL
(	NULL
35	NULL
)	NULL
.	NULL

The	NULL
second	NULL
set	NULL
of	NULL
sequences	NULL
(	NULL
amino	NULL
acids	NULL
240-395	NULL
)	NULL
,	NULL
not	NULL
previously	NULL
identified	NULL
as	NULL
a	NULL
distinct	NULL
functional	NULL
domain	NULL
,	NULL
is	NULL
characterized	NULL
by	NULL
a	NULL
large	NULL
number	NULL
of	NULL
charged	NULL
amino	NULL
acids	NULL
(	NULL
35/155	NULL
)	NULL
and	NULL
proline	NULL
(	NULL
21/155	NULL
)	NULL
residues	NULL
as	NULL
typically	NULL
found	NULL
in	NULL
regulatory	NULL
regions	NULL
of	NULL
transcriptional	NULL
modulators	NULL
.	NULL

One	NULL
simple	NULL
hypothesis	NULL
to	NULL
explain	NULL
the	NULL
synergistic	NULL
activity	NULL
of	NULL
these	NULL
two	NULL
domains	NULL
is	NULL
that	NULL
they	NULL
may	NULL
determine	NULL
the	NULL
conformation	NULL
of	NULL
BCL	NULL
6	NULL
critical	NULL
for	NULL
transrepressive	NULL
function	NULL
.	NULL

Alternatively	NULL
,	NULL
it	NULL
is	NULL
conceivable	NULL
that	NULL
the	NULL
two	NULL
domains	NULL
may	NULL
contribute	NULL
to	NULL
transrepression	NULL
through	NULL
distinct	NULL
mechanisms	NULL
.	NULL

The	NULL
POZ	NULL
domain	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
formation	NULL
of	NULL
multimeric	NULL
protein	NULL
complexes	NULL
and	NULL
their	NULL
targeting	NULL
to	NULL
discrete	NULL
nuclear	NULL
substructures	NULL
(	NULL
35	NULL
)	NULL
,	NULL
while	NULL
the	NULL
structure	NULL
of	NULL
the	NULL
second	NULL
domain	NULL
and	NULL
the	NULL
ability	NULL
of	NULL
BCLG6	NULL
to	NULL
act	NULL
in	NULL
a	NULL
distance-	NULL
and	NULL
orientation-	NULL
independent	NULL
manner	NULL
are	NULL
more	NULL
reminiscent	NULL
of	NULL
silencers	NULL
interfering	NULL
with	NULL
the	NULL
formation	NULL
of	NULL
an	NULL
active	NULL
transcription	NULL
complex	NULL
(	NULL
36	NULL
)	NULL
.	NULL

The	NULL
identification	NULL
of	NULL
molecules	NULL
interacting	NULL
with	NULL
these	NULL
two	NULL
domains	NULL
should	NULL
provide	NULL
insights	NULL
into	NULL
their	NULL
role	NULL
in	NULL
BCL6-mediated	NULL
transrepression	NULL
.	NULL

Implications	NULL
for	NULL
the	NULL
Role	NULL
of	NULL
BCLG	NULL
in	NULL
Normal	NULL
Lymphoid	NULL
Development	NULL
and	NULL
Lymphomagenesis	NULL
.	NULL

The	NULL
BCL-6	NULL
protein	NULL
is	NULL
expressed	NULL
in	NULL
both	NULL
proliferating	NULL
and	NULL
nonproliferating	NULL
B	NULL
cells	NULL
within	NULL
GCs	NULL
,	NULL
but	NULL
not	NULL
in	NULL
pre-GC	NULL
cells	NULL
or	NULL
in	NULL
differentiated	NULL
progenies	NULL
such	NULL
as	NULL
plasma	NULL
cells	NULL
(	NULL
12	NULL
)	NULL
.	NULL

This	NULL
pattern	NULL
suggests	NULL
that	NULL
BCL6	NULL
expression	NULL
may	NULL
be	NULL
needed	NULL
for	NULL
GC	NULL
development	NULL
,	NULL
while	NULL
its	NULL
downregulation	NULL
may	NULL
be	NULL
necessary	NULL
for	NULL
differentiation	NULL
of	NULL
B	NULL
cells	NULL
into	NULL
plasma	NULL
cells	NULL
.	NULL

Based	NULL
on	NULL
these	NULL
observations	NULL
,	NULL
the	NULL
finding	NULL
that	NULL
BCL	NULL
6	NULL
functions	NULL
as	NULL
a	NULL
site-specific	NULL
transcriptional	NULL
repressor	NULL
suggests	NULL
that	NULL
BCL	NULL
6	NULL
may	NULL
regulate	NULL
the	NULL
GC	NULL
phenotype	NULL
by	NULL
silencing	NULL
the	NULL
genes	NULL
determining	NULL
plasma	NULL
cell	NULL
differentiation	NULL
or	NULL
those	NULL
preventing	NULL
the	NULL
death	NULL
of	NULL
B	NULL
cells	NULL
within	NULL
the	NULL
GC	NULL
.	NULL

This	NULL
implies	NULL
that	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
93	NULL
(	NULL
1996	NULL
)	NULL
the	NULL
same	NULL
genes	NULL
,	NULL
and	NULL
thus	NULL
differentiation	NULL
and	NULL
death	NULL
,	NULL
may	NULL
be	NULL
constitutively	NULL
repressed	NULL
in	NULL
lymphomas	NULL
in	NULL
which	NULL
BCL6	NULL
expression	NULL
is	NULL
deregulated	NULL
by	NULL
promoter	NULL
substitution	NULL
or	NULL
mutation	NULL
.	NULL

The	NULL
results	NULL
reported	NULL
in	NULL
this	NULL
study	NULL
provide	NULL
the	NULL
experimental	NULL
framework	NULL
for	NULL
the	NULL
identification	NULL
of	NULL
BCLG6	NULL
target	NULL
genes	NULL
.	NULL

We	NULL
are	NULL
grateful	NULL
to	NULL
K.	NULL
Calame	NULL
,	NULL
L.	NULL
Lania	NULL
,	NULL
F.	NULL
Rauscher	NULL
,	NULL
and	NULL
A.	NULL
Rickinson	NULL
for	NULL
generous	NULL
gifts	NULL
of	NULL
various	NULL
plasmids	NULL
and	NULL
cell	NULL
lines	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Grants	NULL
CA-44029	NULL
(	NULL
to	NULL
R.D.-F.	NULL
)	NULL
and	NULL
CA-34775	NULL
(	NULL
to	NULL
R.S.K.C	NULL
.	NULL
)	NULL

.	NULL

B.H.Y	NULL
.	NULL

is	NULL
supported	NULL
by	NULL
a	NULL
fellowship	NULL
from	NULL
the	NULL
Leukemia	NULL
Society	NULL
of	NULL
America	NULL
.	NULL

1	NULL
.	NULL

Ye	NULL
,	NULL
B.	NULL
H.	NULL
,	NULL
Rao	NULL
,	NULL
P.	NULL
H.	NULL
,	NULL
Chaganti	NULL
,	NULL
R.	NULL
S.	NULL
K.	NULL
&	NULL
Dalla-Favera	NULL
,	NULL
R.	NULL
(	NULL
1993	NULL
)	NULL
Cancer	NULL
Res	NULL
.	NULL

53	NULL
,	NULL
2732-2735	NULL
.	NULL

2	NULL
.	NULL

-	NULL
Ye	NULL
,	NULL
B.	NULL
H.	NULL
,	NULL
Lista	NULL
,	NULL
F.	NULL
,	NULL
Lo	NULL
Coco	NULL
,	NULL
F.	NULL
,	NULL
Knowles	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
Offit	NULL
,	NULL
K.	NULL
,	NULL
Chaganti	NULL
,	NULL
R.	NULL
S.	NULL
K.	NULL
&	NULL
Dalla-Favera	NULL
,	NULL
R.	NULL
(	NULL
1993	NULL
)	NULL
Science	NULL
262	NULL
,	NULL
747-750	NULL
.	NULL

3	NULL
.	NULL

-	NULL
Baron	NULL
,	NULL
B.	NULL
W.	NULL
,	NULL
Nucifora	NULL
,	NULL
G.	NULL
,	NULL
McCabe	NULL
,	NULL
N.	NULL
,	NULL
Espinosa	NULL
,	NULL
R.	NULL
,	NULL
III	NULL
,	NULL
Le	NULL
Beau	NULL
,	NULL
M.	NULL
M.	NULL
&	NULL
McKeithan	NULL
,	NULL
T.	NULL
W.	NULL
(	NULL
1993	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90	NULL
,	NULL
5262-5266	NULL
.	NULL

4	NULL
.	NULL

-	NULL
Kerckaert	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
Deweindt	NULL
,	NULL
C.	NULL
,	NULL
Tilly	NULL
,	NULL
H.	NULL
,	NULL
Quief	NULL
,	NULL
S.	NULL
,	NULL
Lecocq	NULL
,	NULL
G.	NULL
&	NULL
Bastard	NULL
,	NULL
C.	NULL
(	NULL
1993	NULL
)	NULL
Nat	NULL
.	NULL

Genet	NULL
.	NULL

5	NULL
,	NULL
66-70	NULL
.	NULL

5	NULL
.	NULL

Miki	NULL
,	NULL
T.	NULL
,	NULL
Kawamata	NULL
,	NULL
N.	NULL
,	NULL
Hirosawa	NULL
,	NULL
S.	NULL
&	NULL
Aoki	NULL
,	NULL
N.	NULL
(	NULL
1994	NULL
)	NULL
Blood	NULL
83	NULL
,	NULL
26-32	NULL
.	NULL

6	NULL
.	NULL

Lo	NULL
Coco	NULL
,	NULL
F.	NULL
,	NULL
Ye	NULL
,	NULL
B.	NULL
H.	NULL
,	NULL
Lista	NULL
,	NULL
F.	NULL
,	NULL
Corradini	NULL
,	NULL
P.	NULL
,	NULL
Offit	NULL
,	NULL
K.	NULL
,	NULL
Knowles	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
Chaganti	NULL
,	NULL
R.	NULL
S.	NULL
K.	NULL
&	NULL
Dalla-Favera	NULL
,	NULL
R.	NULL
(	NULL
1994	NULL
)	NULL
Blood	NULL
83	NULL
,	NULL
1757-1759	NULL
.	NULL

7	NULL
.	NULL

Bastard	NULL
,	NULL
C.	NULL
,	NULL
Deweindt	NULL
,	NULL
C.	NULL
,	NULL
Kerckaert	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
Lenormand	NULL
,	NULL
B.	NULL
,	NULL
Rossi	NULL
,	NULL
A.	NULL
,	NULL
Pezzella	NULL
,	NULL
F.	NULL
,	NULL
Fruchart	NULL
,	NULL
C.	NULL
,	NULL
Duval	NULL
,	NULL
C.	NULL
,	NULL
Monconduit	NULL
,	NULL
M.	NULL
&	NULL
Tilly	NULL
,	NULL
H.	NULL
(	NULL
1994	NULL
)	NULL
Blood	NULL
83	NULL
,	NULL
2423-2427	NULL
.	NULL

8	NULL
.	NULL

-	NULL
Otsuki	NULL
,	NULL
K.	NULL
,	NULL
Yano	NULL
,	NULL
T.	NULL
,	NULL
Clark	NULL
,	NULL
H.	NULL
H.	NULL
,	NULL
Bastard	NULL
,	NULL
C.	NULL
,	NULL
Kerckaert	NULL
,	NULL
J.-P.	NULL
,	NULL
Jaffe	NULL
,	NULL
E.	NULL
S.	NULL
&	NULL
Raffeld	NULL
,	NULL
M.	NULL
(	NULL
1995	NULL
)	NULL
Blood	NULL
85	NULL
,	NULL
2877-2884	NULL
.	NULL

9	NULL
.	NULL

Ye	NULL
,	NULL
B.	NULL
H.	NULL
,	NULL
Chaganti	NULL
,	NULL
S.	NULL
,	NULL
Chang	NULL
,	NULL
C.-C.	NULL
,	NULL
Niu	NULL
,	NULL
H.	NULL
,	NULL
Corradini	NULL
,	NULL
P.	NULL
,	NULL
Chaganti	NULL
,	NULL
R.	NULL
S.	NULL
K.	NULL
&	NULL
Dalla-Favera	NULL
,	NULL
R.	NULL
(	NULL
1995	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

14	NULL
,	NULL
6209-6217	NULL
.	NULL

10	NULL
.	NULL

Migliazza	NULL
,	NULL
A.	NULL
,	NULL
Martinotti	NULL
,	NULL
S.	NULL
,	NULL
Chen	NULL
,	NULL
W.	NULL
,	NULL
Fusco	NULL
,	NULL
C.	NULL
,	NULL
Ye	NULL
,	NULL
B.	NULL
H.	NULL
,	NULL
Knowles	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
Offit	NULL
,	NULL
K.	NULL
,	NULL
Chaganti	NULL
,	NULL
R.	NULL
S.	NULL
K.	NULL
&	NULL
Dalla-Favera	NULL
,	NULL
R.	NULL
(	NULL
1995	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92	NULL
,	NULL
12520-12524	NULL
.	NULL

11	NULL
.	NULL

Dalla-Favera	NULL
.	NULL

R.	NULL
,	NULL
Ye	NULL
,	NULL
B.	NULL
H.	NULL
,	NULL
Lo	NULL
Coco	NULL
,	NULL
F.	NULL
,	NULL
Chang	NULL
,	NULL
C.-C.	NULL
,	NULL
Cechova	NULL
,	NULL
K.	NULL
,	NULL
Zhang	NULL
,	NULL
J.	NULL
,	NULL
Migliazza	NULL
,	NULL
A.	NULL
,	NULL
Mellado	NULL
,	NULL
W.	NULL
,	NULL
Niu	NULL
,	NULL
H.	NULL
,	NULL
Chaganti	NULL
,	NULL
S.	NULL
,	NULL
Chen	NULL
,	NULL
W.	NULL
,	NULL
Rao	NULL
,	NULL
P.	NULL
H.	NULL
,	NULL
Parsa	NULL
,	NULL
N.	NULL
Z.	NULL
,	NULL
Louie	NULL
,	NULL
D.	NULL
C.	NULL
,	NULL
Offit	NULL
,	NULL
K.	NULL
&	NULL
Chaganti	NULL
,	NULL
R.	NULL
S.	NULL
K.	NULL
(	NULL
1994	NULL
)	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Symp	NULL
.	NULL

Quant	NULL
.	NULL

Biol	NULL
.	NULL

59	NULL
,	NULL
117-123	NULL
.	NULL

12	NULL
.	NULL

Cattoretti	NULL
,	NULL
G.	NULL
,	NULL
Chang	NULL
,	NULL
C.-C.	NULL
,	NULL
Cechova	NULL
,	NULL
K.	NULL
,	NULL
Zhang	NULL
,	NULL
J.	NULL
,	NULL
Ye	NULL
,	NULL
B.	NULL
H.	NULL
,	NULL
Falini	NULL
,	NULL
B.	NULL
Louie	NULL
,	NULL
D.	NULL
C.	NULL
,	NULL
Offit	NULL
,	NULL
K.	NULL
,	NULL
Chaganti	NULL
,	NULL
R.	NULL
S.	NULL
K.	NULL
&	NULL
Dalla-Favera	NULL
,	NULL
R.	NULL
(	NULL
1995	NULL
)	NULL
Blood	NULL
86	NULL
,	NULL
45-53	NULL
.	NULL

13	NULL
.	NULL

Onizuka	NULL
,	NULL
T.	NULL
,	NULL
Moriyama	NULL
,	NULL
M.	NULL
,	NULL
Yamochi	NULL
,	NULL
T.	NULL
,	NULL
Kuroda	NULL
,	NULL
T.	NULL
,	NULL
Kazama	NULL
,	NULL
A.	NULL
,	NULL
Kanazawa	NULL
,	NULL
N.	NULL
,	NULL
Sato	NULL
,	NULL
K.	NULL
,	NULL
Kato	NULL
,	NULL
T.	NULL
,	NULL
Ota	NULL
,	NULL
H.	NULL
&	NULL
Mori	NULL
,	NULL
S.	NULL
(	NULL
1995	NULL
)	NULL
Blood	NULL
86	NULL
,	NULL
25-37	NULL
.	NULL

14	NULL
.	NULL

-	NULL
Flenghi	NULL
,	NULL
L.	NULL
,	NULL
Ye	NULL
,	NULL
B.	NULL
H.	NULL
,	NULL
Fizzotti	NULL
,	NULL
M.	NULL
,	NULL
Bigerna	NULL
,	NULL
B.	NULL
,	NULL
Cattoretti	NULL
,	NULL
G.	NULL
,	NULL
Venturi	NULL
,	NULL
S.	NULL
,	NULL
Pacini	NULL
,	NULL
R.	NULL
,	NULL
Pileri	NULL
,	NULL
S.	NULL
,	NULL
Lo	NULL
Coco	NULL
,	NULL
F.	NULL
,	NULL
Pescarmona	NULL
,	NULL
E.	NULL
,	NULL
Pelicci	NULL
,	NULL
P.-G.	NULL
,	NULL
Dalla-Favera	NULL
,	NULL
R.	NULL
&	NULL
Falini	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Am	NULL
.	NULL

J.	NULL
Pathol	NULL
.	NULL

145	NULL
,	NULL
405-411	NULL
.	NULL

15	NULL
.	NULL

-	NULL
Baron	NULL
,	NULL
B.	NULL
W.	NULL
,	NULL
Stanger	NULL
,	NULL
R.	NULL
R.	NULL
,	NULL
Hume	NULL
,	NULL
E.	NULL
,	NULL
Sadhu	NULL
,	NULL
A.	NULL
,	NULL
Mick	NULL
,	NULL
R.	NULL
,	NULL
Kerckaert	NULL
,	NULL
J.-P.	NULL
,	NULL
Deweindt	NULL
,	NULL
C.	NULL
,	NULL
Bastard	NULL
,	NULL
C.	NULL
,	NULL
Nucifora	NULL
,	NULL
G.	NULL
,	NULL
Aeleznik-Le	NULL
,	NULL
N.	NULL
&	NULL
McKeithan	NULL
,	NULL
T.	NULL
W.	NULL
(	NULL
1994	NULL
)	NULL
Genes	NULL
Chromosomes	NULL
Cancer	NULL
13	NULL
,	NULL
221-224	NULL
.	NULL

16	NULL
.	NULL

-	NULL
Kawamata	NULL
,	NULL
N.	NULL
,	NULL
Miki	NULL
,	NULL
Tk	NULL
.	NULL

,	NULL
Ohashi	NULL
,	NULL
K.	NULL
,	NULL
Suzuki	NULL
,	NULL
K.	NULL
,	NULL
Fukuda	NULL
,	NULL
T.	NULL
,	NULL
Hirosawa	NULL
,	NULL
S.	NULL
&	NULL
Aoki	NULL
,	NULL
N.	NULL
(	NULL
1994	NULL
)	NULL
Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

204	NULL
,	NULL
366-374	NULL
.	NULL

17	NULL
.	NULL

-	NULL
Numoto	NULL
,	NULL
M.	NULL
,	NULL
Niwa	NULL
,	NULL
O.	NULL
,	NULL
Kaplan	NULL
,	NULL
J.	NULL
,	NULL
Wong	NULL
,	NULL
K.-K.	NULL
,	NULL
Merrell	NULL
,	NULL
K.	NULL
,	NULL
Kamiya	NULL
,	NULL
K.	NULL
,	NULL
Yanagihara	NULL
,	NULL
K.	NULL
&	NULL
Calame	NULL
,	NULL
K.	NULL
(	NULL
1993	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

21	NULL
,	NULL
3767-3775	NULL
.	NULL

18	NULL
.	NULL

Zollman	NULL
,	NULL
S.	NULL
,	NULL
Godt	NULL
,	NULL
D.	NULL
,	NULL
Prive	NULL
,	NULL
G.	NULL
G.	NULL
,	NULL
Couderc	NULL
,	NULL
J.-L.	NULL
&	NULL
Laski	NULL
,	NULL
F.	NULL
A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91	NULL
,	NULL
10717-10721	NULL
.	NULL

19	NULL
.	NULL

Bardwell	NULL
,	NULL
V.	NULL
J	NULL
.	NULL

&	NULL
Treisman	NULL
,	NULL
R.	NULL
(	NULL
1994	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

8	NULL
,	NULL
1664-1677	NULL
.	NULL

20	NULL
.	NULL

-	NULL
Harrison	NULL
,	NULL
S.	NULL
D.	NULL
&	NULL
Travers	NULL
,	NULL
A	NULL
.	NULL

A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

9	NULL
,	NULL
207-216	NULL
.	NULL

R	NULL
21	NULL
.	NULL

DiBello	NULL
,	NULL
P.	NULL
R.	NULL
,	NULL
Withers	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
Bayer	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
Bayer	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
Fristrom	NULL
,	NULL
J.	NULL
W.	NULL
&	NULL
Guild	NULL
,	NULL
G.	NULL
M.	NULL
(	NULL
1991	NULL
)	NULL
Genetics	NULL
129	NULL
,	NULL
385-397	NULL
.	NULL

22	NULL
.	NULL

Chardin	NULL
,	NULL
P.	NULL
,	NULL
Courtois	NULL
,	NULL
G.	NULL
,	NULL
Mattei	NULL
,	NULL
M.	NULL
-G.	NULL
&	NULL
Gisselbrecht	NULL
,	NULL
S.	NULL
(	NULL
1991	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

19	NULL
,	NULL
1431-1436	NULL
.	NULL

23	NULL
.	NULL

Chen	NULL
,	NULL
Z.	NULL
,	NULL
Brand	NULL
,	NULL
N.J.	NULL
,	NULL
Chen	NULL
,	NULL
A.	NULL
,	NULL
Chen	NULL
.	NULL

,	NULL
S.	NULL
,	NULL
Tong	NULL
,	NULL
J.-H.	NULL
,	NULL
Wang	NULL
,	NULL
Z.-Y	NULL
.	NULL

,	NULL
Waxman	NULL
,	NULL
S.	NULL
&	NULL
Zelent	NULL
,	NULL
A	NULL
(	NULL
1993	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

12	NULL
,	NULL
1161-1167	NULL
.	NULL

24	NULL
.	NULL

Koonin	NULL
,	NULL
E.	NULL
V.	NULL
,	NULL
Senkevich	NULL
,	NULL
T.	NULL
G.	NULL
&	NULL
Chernos	NULL
,	NULL
V.	NULL
I	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

17	NULL
,	NULL
213-214	NULL
.	NULL

25	NULL
.	NULL

Xue	NULL
,	NULL
F.	NULL
&	NULL
Cooley	NULL
,	NULL
L	NULL
(	NULL
1993	NULL
)	NULL
Cell	NULL
72	NULL
,	NULL
681-693	NULL
.	NULL

26	NULL
.	NULL

Lillie	NULL
,	NULL
J.	NULL
W.	NULL
&	NULL
Green	NULL
,	NULL
M.	NULL
R.	NULL
(	NULL
1989	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
338	NULL
,	NULL
39-44	NULL
.	NULL

27	NULL
.	NULL

Pengue	NULL
,	NULL
G.	NULL
,	NULL
Calabr6	NULL
,	NULL
V.	NULL
,	NULL
Cannada	NULL
Bartoli	NULL
,	NULL
P.	NULL
,	NULL
Pagliuca	NULL
,	NULL
A	NULL
.	NULL

&	NULL
Lania	NULL
,	NULL
L.	NULL
(	NULL
1994	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

22	NULL
,	NULL
2908-2914	NULL
.	NULL

28	NULL
.	NULL

Madden	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
Cook	NULL
,	NULL
D.	NULL
M.	NULL
&	NULL
Rauscher	NULL
,	NULL
F.	NULL
J.	NULL
,	NULL
III	NULL
(	NULL
1993	NULL
)	NULL
Oncogene	NULL
8	NULL
,	NULL
1713-1720	NULL
.	NULL

29	NULL
.	NULL

Gregory	NULL
,	NULL
C.	NULL
D.	NULL
,	NULL
Rowe	NULL
,	NULL
M.	NULL
&	NULL
Rickinson	NULL
,	NULL
A	NULL
.	NULL

B	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
J.	NULL
Gen.	NULL
Virol	NULL
.	NULL

71	NULL
,	NULL
1481-1495	NULL
.	NULL

30	NULL
.	NULL

-	NULL
Chang	NULL
,	NULL
C.-C.	NULL
,	NULL
Zhang	NULL
,	NULL
J.	NULL
,	NULL
Lombardi	NULL
,	NULL
L.	NULL
,	NULL
Neri	NULL
,	NULL
A	NULL
.	NULL

&	NULL
Dalla-Favera	NULL
,	NULL
R.	NULL
(	NULL
1995	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15	NULL
,	NULL
5180-5188	NULL
.	NULL

31	NULL
.	NULL

-	NULL
Wright	NULL
,	NULL
E.	NULL
M.	NULL
,	NULL
Binder	NULL
,	NULL
M.	NULL
&	NULL
Funk	NULL
,	NULL
W.	NULL
(	NULL
1991	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11	NULL
,	NULL
4104-4110	NULL
.	NULL

32	NULL
.	NULL

Giniger	NULL
,	NULL
E.	NULL
,	NULL
Varnum	NULL
,	NULL
S.	NULL
&	NULL
Ptashne	NULL
,	NULL
M.	NULL
(	NULL
1985	NULL
)	NULL
Cell	NULL
40	NULL
,	NULL
767-774	NULL
.	NULL

33	NULL
.	NULL

Liu	NULL
,	NULL
Q.	NULL
,	NULL
Shalaby	NULL
,	NULL
F.	NULL
,	NULL
Puri	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
Tang	NULL
,	NULL
S.	NULL
&	NULL
Breitman	NULL
,	NULL
M.	NULL
L.	NULL
(	NULL
1994	NULL
)	NULL
Dev	NULL
.	NULL

Biol	NULL
.	NULL

165	NULL
,	NULL
165-177	NULL
.	NULL

34	NULL
.	NULL

-	NULL
Deweindt	NULL
,	NULL
C.	NULL
,	NULL
Albagli	NULL
,	NULL
O.	NULL
,	NULL
Bernardin	NULL
,	NULL
F.	NULL
,	NULL
Dhordain	NULL
,	NULL
P.	NULL
,	NULL
Quief	NULL
,	NULL
S.	NULL
,	NULL
Lantoine	NULL
,	NULL
D.	NULL
,	NULL
Kerckaert	NULL
,	NULL
J.	NULL
P.	NULL
&	NULL
Leprince	NULL
,	NULL
D.	NULL
(	NULL
1995	NULL
)	NULL
Cell	NULL
Growth	NULL
Differ	NULL
.	NULL

6	NULL
,	NULL
1495-1503	NULL
.	NULL

35	NULL
.	NULL

Albagli	NULL
,	NULL
O.	NULL
,	NULL
Dhordain	NULL
,	NULL
C.	NULL
,	NULL
Deweindt	NULL
,	NULL
C.	NULL
,	NULL
Lecocq	NULL
,	NULL
G.	NULL
,	NULL
Leprince	NULL
,	NULL
D.	NULL
(	NULL
1995	NULL
)	NULL
Cell	NULL
Growth	NULL
Diff	NULL
.	NULL

6	NULL
,	NULL
1193-1198	NULL
.	NULL

36	NULL
.	NULL

Cowell	NULL
,	NULL
I.	NULL
G.	NULL
(	NULL
1994	NULL
)	NULL
Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

19	NULL
,	NULL
38-42	NULL
.	NULL

37	NULL
.	NULL

-	NULL
Chen	NULL
,	NULL
W.	NULL
,	NULL
Zollman	NULL
,	NULL
S.	NULL
,	NULL
Couderc	NULL
,	NULL
J.-L.	NULL
&	NULL
Laski	NULL
,	NULL
F.	NULL
A	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15	NULL
,	NULL
3424-3429	NULL
.	NULL

